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1  Introduction 
The investigation of this pilot study based on the modern system pharmacological 
research field about dysfunction analysis of the blood-brain barrier (BBB). The main 
topics of the BBB research group at the Department of Medicinal/Pharmaceutical 
Chemistry from University Vienna, head Univ. Prof. Dr. Mag. DI Christian R. Noe are 
the pharmaceutical research on the biological system BBB. Three major topics are 
involved in the research of drug discovery on BBB models: 
 Transport studies 
 Drug impact studies 
 BBB as drug target 
This work is part of the BBB drug target research based on modern system 
pharmacology approaches Using human primary cells (HUVEC) and immortalized 
porcine brain cells (PBMEC/C1-2) for different BBB models to identify via mass 
spectrometric methods molecules of interests. Those molecules should be starting 
points for further pilot studies in BBB dysfunction research.  
The BBB is a system for it selves with a variety of important function as: 
 regulatory element 
 gate keeper to the central nervous system (CNS) 
 transport barrier for nutrition 
Many dysfunctions especially due to aging processes lead to neurodegeneration and 
pathological circumstances in the brain. In this study the overall purpose is to 
understand further mechanism of the BBB as pharmacological treatment element. 
The next parts show an overview of the physiology and morphology of the BBB, their 
transport pathways and the pathology.  
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1.1 What is the Blood- Brain Barrier? 
1.1.1 Historical approach 
The existence of the blood-brain barrier has been recognized for more than 100 
years and was first experimentally demonstrated by the German scientist Paul 
Ehrlich. He conducted experiments of dye injections administered into the circulation 
system. Ehrlich observed that certain dyes were rapidly taken up into the body with 
the exception of the spinal cord and brain (Ehrlich 1904). First he thought that these 
differences could be interpreted as a lack of affinity for these dyes and the cerebral 
vascular endothelium within the nervous system. Edwin E. Goldman, an assistant of 
Ehrlich, demonstrated that the same dyes injected into the cerebrospinal fluid readily, 
stained solely nervous tissue (Engelhardt and Sorkin 2009). With these findings the 
understanding of a barrier inside the brain began (Bradbury 1979) and was firstly 
named “blood-brain barrier” by Lewandowsky in the year 1890.  
The importance of the blood-brain barrier was shown in many further experiments 
revealing the signaling functions between glia cells and endothelium responsible for 
the regulation capacity of the BBB. Ultrastructure studies pointed out that BBB 
endothelial cells (ECs) differ fundamentally from most peripheral tissues. They have 
very few endocytotic vesicles which cause a limited amount of transcellular flux 
(Rubin and Staddon 1999). Specialized features and properties of the BBB are 
induced by cell-cell interactions. The BBB is definitely a dynamic system with 
complex pathways of modulation and transport alterable due to outer circumstances.  
 
The blood-brain barrier (BBB) is part of the brain and has an important protective 
function for the central nervous system (CNS). The BBB acts as physical and 
metabolic barrier and is formed by endothelial cells (lining cerebral microvessels). It 
separates the systemic blood circulation from the CNS. The CNS is a highly sensitive 
system in the body and has to be protected from toxic and pathogenic agents found 
in the blood, which are capable of disturbing neuronal functions. Overall, there are 
three barriers described inside the brain with the main function of regulating the 
molecular exchange at the interfaces between blood and neural tissue (Abbott 2006). 
The BBB is formed by the cerebrovascular endothelial cells, the choroid plexus 
epithelium between blood and ventricular CSF and the arachnoid epithelium between 
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blood and subarachnoid CSF. Another important function of the brain barriers is the 
aspect that they are involved in the control mechanisms of cerebral homeostasis. 
This kind of regulation of the brain microenvironment is necessary for healthy 
functions of the CNS. The position of the three brain barriers in the CNS are shown in 
figure 1. 
 
Figure 1: Scheme of the barriers in the brain (Picture is adapted from Abbott et al 2010) 
The localizations of the three brain barriers are represented. a) The BBB, the largest surface area for 
exchange with a size of 12 to 18 m
2
 in adult humans, b) the blood-CSF barrier at the choroid plexus in 
the lateral third and fourth ventricles of the brain and c) the arachnoid barrier, which lies under the 
dura, enveloped by the arachnoid membrane (Abbott et al. 2010) 
 
1.2 Morphology and Physiology of the BBB 
The blood-brain barrier acts as a physical barrier with tight junctions between 
endothelial cells to enable molecular transport. Small gaseous molecules as well as 
small lipophilic agents can diffuse freely through the lipid membrane (Abbott et al. 
2006). In the region of the luminal and abluminal membranes of the BBB there are 
specific transport systems that regulate ionic traffic permitting entry of required 
nutrients or efflux of potential harmful substances. Tight junctions limit the crossover 
of large molecules and hydrophilic drugs into the brain and protect them from an 
influx of toxic compositions. Basically the BBB is located in all brain regions. 
Exceptions in this context are the circumventricular organs including area postrema, 
median eminence, neurohypophysis, pineal gland, subfornical organ and lamina 
terminalis. The blood vessels of these brain areas are supplied with blood-borne 
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molecules which pass the vessel wall through diffusion. These unprotected fields of 
the brain are separately regulated by the autonomic nervous system and endocrine 
glands (Ballabh et al. 2003). 
Hence, the BBB provides the brain with essential nutrients and mediates efflux of 
many waste products. It restricts ionic and fluid movements between the blood and 
the brain by ion transport systems and contributes to the production of brain 
interstitial fluid (ISF) which guarantees neuronal function in an optimal medium.  
Specific characteristics of the BBB endothelium, such as tight junctions, astrocytes 
and neurons, enable the correct function of CNS processes. The BBB is formed by 
capillary endothelial cells, enveloped by basal lamina and astrocytic perivascular 
endfeet. The connection between basal lamina and neurons is provided by 
astrocytes. Pericytes are distributed inside the basal lamina and microglias are part 
of the surroundings of the astrocytic endfeet. All these components [Figure 2] form 
the “neurovascular unit” that has an enormous influence on health and proper 
function of the CNS (Engelhardt and Sorokin 2009). 
 
Figure 2:  Scheme of the “neurovascular unit” (Picture is adapted from Abbott et al. 2010) 
The main components and the structure of the blood brain barrier are shown. Adjacent capillary 
endothelial cells form tight junctions, surrounded by basal lamina, pericytes and astrocytic endfeet. 
Astrocytes make the link to the neurons. (Abbott et al. 2009). 
1.2.1 The components of the BBB  
Main task of the BBB is the maintenance of the homeostasis in the central nervous 
system (CNS). The main components of the BBB are the endothelial cells which line 
the lumen of the blood capillaries in the brain. The properties of the endothelial cells 
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of the BBB are determined by their environment. Signaling from neighbored 
pericytes, astrocytes, neurons and probably shear stress influence the functionality of 
the BBB. 
Endothelial cells 
BBB endothelial cells harbor tight junctions within their cell-cell contacts. Tight 
junctions are typical hallmarks of the BBB. The junction complex consists of 
adherens junctions (AJs) and tight junctions (TJs). They regulate the paracellular flux 
pathway and effectively block penetrations of macromolecules and other harmful 
substances. In contrast, small molecules like O2 and CO2 can enter through diffusion 
across the membrane along their concentration gradient. Lots of junction molecules 
are involved in the regulation of the permeability process in endothelial cells [see also 
chapter 1.2.2 The tight junction complex].  
The electrical resistance of measured transendothelial cells was about 1500-2000 
Ωxcm2. That seems rather high compared to other endothelial cells as human 
placenta cells with the resistance of 22-52 Ωxcm2 (Huber et al 2001, Abbott et al. 
2003). The effect of that strong resistance is the impediment of ionic movement, the 
protection of the brain and the maintenance of homeostasis. 
Basal lamina 
The basal lamina forms a layer around cerebral endothelial cells. Inside the basal 
lamina 1 [Figure 2] pericytes and smooth muscle cells are enclosed. The basal 
lamina 2 forms an extracellular matrix providing contact among cerebral endothelial 
and surrounding cells. 
Astrocytes 
Astrocytes supply stimulating factors to the basal surface of brain capillary ECs. 
These factors are important for complete BBB formation, so astrocytes might induce 
ECs to adopt a brain phenotype (Rubin and Staddon 1999, Grant et al 1998). Many 
experiments showed that endfeet of astrocytes are close to the capillary endothelium 
releasing chemical signals for induction and maintenance of the BBB.  
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Neurons and Microglia 
Axonal projections from neurons onto arteriolar smooth muscles contain vasoactive 
neurotransmitters and peptides which regulate local cerebral blood (Abbott et al. 
2010). Microglia are resident macrophages of the brain and spinal cord and act in the 
active immune system as key cellular mediators in inflammatory processes. 
1.2.2 The tight junction complex 
Endothelial cells are joined by the junctional complex area which is a substantial 
junctional cleft. The junctional complex is built up by tight junctions (TJs) and 
adherens junctions (AJs). Both form a continuous network of parallel, interconnected, 
intramembrane strands of proteins representing a range of multiple barriers (Huber et 
al. 2001).The graphics below [Figure 3] demonstrates the structure of the tight 
junction complex.  
 
Figure 3: The tight junction complex with its components is shown in this graphic. (Picture is adapted 
from Huber et al. 2001) The two main structures are the adherens junctions (AJs) and the tight 
junctions (TJs). Other important regulation elements are junctional proteins with their multiple functions 
of development and maintenance of the BBB.  
Adherens junctions (AJs) play an important role in development and formation of 
tight junctions. The contact between adjacent cells is dependent on membrane 
proteins named cadherins. Cadherins are single-pass transmembrane glycoproteins 
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that interact homotypically in the presence of Ca2+ (Rubin and Staddon 1999). 
Cadherins associate with other proteins termed catenins, which consist of three 
different types (α, β and γ Catenin). Catenin β and γ are combined and connected 
with α catenin that links them to the actin-based cytoskeleton. Via this pathway 
signaling components may be activated to allow communication between adherens 
and tight junctions. Within the basolateral membrane endothelial cells are joined by 
tight junction proteins, namely claudins and junctional adhesion molecules. These 
proteins form the backbone of TJs (Huber et al. 2001). They are linked to an actin-
based cytoskeleton allowing TJs the capacity of rapid modulation and regulation. 
1.2.3 Tight junction molecules 
Occludin 
Occludin was the first tight junction transmembrane protein which was discovered in 
1993. It is a 65 kDa integral membrane phosphoprotein with four transmembrane 
domains that exist exclusively in tight junction strands. The real function of occludin is 
more complex than previously expected. However, some experiments in occludin-
deficient mice showed that tight junctions were morphologically not affected and 
transepithelial resistance in small and large intestine epithelial cells did not differ from 
measurements in wild type mice. Abnormalities, such as chronic inflammation and 
hyperplasia of the gastric epithelium, calcification in the brain, testicular atrophy, loss 
of cytoplasmic granules in striated duct cells of the salivary gland, and thinning of the 
compact bone, were found in several tissues (Saitou et al. 2000). These results are 
indices for the complex function of tight junctions (TJs). Phosphorylated occludin 
proved to have only low influence on TJ regulation (Wolburg and Lippoldt 2002), 
nevertheless extensive phosphorylation of occludin occurs when the cytoplasmic 
domain is localized within the tight junction. In MDCK cells occludin exists in many 
phosphorylation states. It was shown that especially serin phosphorylation is 
responsible for the stabilization of membrane associated occludin (Kniesel and 
Wolburg 1998). It was observed that occludin is not required for the formation of tight 
junction strands but that it is responsible for the sealing of tight junctions (Sakakibara 
et al. 1997; Lacaz-Vieira et al. 1999). Furthermore, occludin was shown to be 
necessary for mature cells to gain the right properties for barrier function. 
Additionally, the presence of the regulatory protein in the BBB is correlated with 
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increased electrical resistance across the barrier and decreased paracellular 
permeability (Huber et al. 2001). 
Claudin 
Claudins are 22 kDA phosphoproteins which form dimers that bind homo directly to 
claudine of adjacent endothelial cells. Claudins belong to the multigene 
PMP22/EMP/MP20 claudin family of proteins that comprise many isoforms, of which 
at least 24 have been identified in mammals (Huber et al. 2001). Claudin-1 and 
Claudin-2 are integral components of the tight junction strands. They are one of the 
major elements in the TJ complex and build up a primary seal of tight junction 
proteins (Furuse et al. 1999). The carboxy terminal of claudins binds to other proteins 
inside the cytoplasm like cytoplasmic accessory proteins (ZO1, ZO2). Claudin-1 and 
Claudin-5, together with Occludin, have an important influence in the establishment 
of barrier properties. Another well known member inside the claudin family is the 
oligodendrocyte protein (OSP), also called Claudin-11. It is a major part of the CNS 
myelin sheat and of Sertoli cells of the blood-testis barrier (Ballabh P et al. 2003). 
Functional investigations showed that claudins directly determine barrier functions. 
Tight junction-negative L-fibroblasts were transfected with claudins and formed tight 
junctions associated with P-face and E-face. They form very long and branched 
strands. In contrast, occludin induces short strands and was found to be localized at 
both fracture faces (Hirase et al. 1997; Furuse et al. 2001). 
Junctional adhesion molecules (JAMs)  
In general junctional adhesion molecules (JAMs) are compounds of the tight junction 
complex that may regulate the transendothelial migration of leukocytes, and are 
involved in the maintenance of the TJ, but their whole function in the BBB is still 
unclear (Abbott et al. 2010). The JAM family consists of three different types of 
molecules, called JAM-1, JAM-2 and JAM-3 all of them belonging to the 
immunoglobulin superfamiliy. Mediations of these molecules are performed by 
hemophilic and also heterophilic interactions. JAM-1 is a 40 kDa transmembrane 
protein with a large extracellular domain. This member of the IgG superfamiliy 
mediates the early attachment of adjacent endothelial cells through hemophilic 
interaction. Via a PDZ binding motif at the carboxy terminus JAM-1 binds to ZO-1, 
AF-6/afadin, cingulin and Cas kinase/lin-2 (Martinez-Estrada et al. 2001). 
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Experiments showed that JAM-1 increases the cellular resistance in cells which 
normally does not form tight junctions. Another effect is the reduction of paracellular 
permeability. Therefore JAM-1 also has an impact on the localization of occludin. It 
seems that the molecule has an organizing function to build up the right junctional 
structure (Wolburg and Lippoldt 2002). JAM-2 and JAM-3 are present in endothelial 
tissue and lymphatic cells with the exception of epithelial cells (Hawkins and Davis 
2005). 
Membrane-Associated Guanylate Kinase-Like Proteins (MAGUK) 
Membrane-Associated Guanylate Kinase-Like Proteins (MAGUK) are accessory 
proteins in the cytoplasm of BBB endothelial cells. Three different types of MAGUK 
proteins have been identified in the tight junction complex, named zonula occludens 
(ZO-1, ZO-2 and ZO-3). Zonula occludens (ZO) are adapter proteins that bind to 
intramembrane proteins. ZO-1 is a 220 kDa phosphoprotein expressed not only in 
endothelial cells but also in cells without TJs. The main action of ZO-1 is the linkage 
of transmembrane proteins at TJs to the actin based cytoskeleton via ZO-2 or ZO-3. 
This interaction is important for proper structure conditions within the cytoplasm and 
for an efficient function of TJs. Absence of ZO-1 at the junctional complex has 
increased permeability effects on the BBB. This accessory protein acts as response 
molecule in intracellular signal transduction (Hawkins and Davis 2005). ZO-2 is a 160 
kDa phosphoprotein that shows a high sequence homology to ZO-1. Normally ZO-2 
is located along the membrane. However, during stress and proliferation the adaptor 
protein is turned into the nucleus. Interestingly, ZO-2 has also been found in cells 
without tight junctions. The third adaptor protein, ZO-3, has a molecular weight of 130 
kDa and is solely found in endothelial tight junctions, where it regulates the 
interaction of cytoplasm components with the actin-based cytoskeleton. 
Other Accessory Proteins 
Other accessory proteins are elements of the endothelial cytoplasm within the tight 
junctional complex. Among these proteins there are AF6 and 7H6 which both interact 
with junctional adhesion molecules. Cingulin is connected with ZOs, JAMS and 
myosin for passing on the signals from TJs to the cytoskeleton and vice versa. Inside 
the adherens junctions α-actinin and vinculin interact directly with the actin-based 
cytoskeleton and transfer the information from the adherens junction by Catenins.  
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1.3 Transport systems across the BBB 
For the maintenance of homeostasis in the CNS, the blood-brain barrier selectively 
transports nutrients into the brain via multiple transport mechanisms (Huber et al 
2001). Several pathways across the blood-brain barrier are shown below in figure 4. 
 
Figure 4: Scheme of the transport pathways through the BBB (Picture is adapted from Abbott et al. 
2010). a) Passive diffusion: Solutes pass the membrane by passively diffusing into the cell. b) ABC 
Transporter Efflux: The ATP-binding cassette transporters (ABC transporters) in the BBB actively 
pump neurotoxic substances out of the brain against a concentration gradient. For this process ATP is 
required. c) Solute Carriers (SLC): The SLC transport substances act on a bi-directional way in or out 
of the brain. The transport direction depends on the substrate concentration gradient. d) RMT and 
AMT: Receptor-mediated transcytosis (RMT) needs a receptor on the surface of the cell that 
recognizes the ligand and subsequently transports the molecule inside the vessel through the 
membrane. (Adsorptive-mediated transcytosis) AMT: Instead of the receptor the positively charged 
macromolecule triggers the start of endocytotic mechanisms. e) Immune respondent cells are able to 
penetrate the membrane under pathological or pharmacologically induced conditions.  
The transport pathways through endothelial tight junctions have been divided in five 
subtypes. (a) Passive diffusion directly through the membrane (Fig. 1.3a) 
represents the transport of soluble, lipid and non-polar molecules, such as water, 
oxygen and carbon dioxide. The endothelium contains several proteins with carrier 
functions for the transport of nutrients such as glucose, amino acids and other 
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substances into the brain and specific efflux carriers which eliminate toxic substances 
from the brain.  
(b) ABC transporters are active efflux carriers that pump molecules either directly 
out of the cell or on their way to cross the membrane. Members of the ABC 
transporter system in BBB are the Multidrug Resistance Proteins (MDRs), the 
Multidrug Resistance-related Proteins (MRPs) and Breast Cancer Resistance 
Proteins (BRCP). The first identified MDR protein was P-glycoprotein (p-gp, MDR1) 
an ATP dependent efflux carrier that prevents the traverse of xenobiotics and drugs 
(e.g. lipid glucocorticoid, cholesterol, peptides and drugs) into the brain. The major 
role of ABC transporters is the active efflux of various lipid-soluble compounds out of 
the brain. In this process the compounds are pumped out of the brain against a 
concentration gradient, for which the required energy is delivered by ATP (Carvey et 
al. 2009, Abbott et al. 2010).  
There are specific requirements for a substance that determine the way of transport 
through the endothelial membrane such as structural features, lipid solubility and 
electrical charge. Efflux systems play an important role in establishing and 
maintaining the homeostatic level of the CNS. An effective efflux can inhibit a drug to 
become potentially neurotoxic and/or to develop a therapeutic effect inside the CNS 
(Banks 1999).  
(c) SLCs (solute carriers) enable the entrance of polar nutrients that are important for 
the CNS metabolism. These proteins are located at the apical and basal membrane 
side. SLC proteins transport substances on a bi-directional way in or out of the brain. 
The transport direction depends on the substrate concentration gradient. There are 
four different SLC pathways: (1) unidirectional, meaning either into or out of the cell, 
(2/3) substrate exchange, one substrate gets in the brain and another is pumped out 
in a parallel manner, and (4) reversible transport which depends on an 
electrochemical gradient (Abbott. et al 2010). 
(d) RMT and AMT (Transcytosis Receptor-Mediated and Adsorptive-Mediated 
Transport). RMT is an important way how large molecules can be moved into the cell. 
The molecule binds to a receptor at the luminal side of the endothelium initiating the 
process of transcytosis which means that the ligand is transported across the 
membrane inside the vesicle. Examples of these receptors are the transferrin 
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receptor, the insulin receptor or the LDL receptor (Carvey et al. 2009). AMT is not 
receptor-mediated and specific for positively charged macromolecules, which can be 
transported across the membrane through endocytotic mechanisms.  
(e) Mononuclear Cell Migration is a method where immune cells are able to pass 
the membrane under pathological or pharmacologically induced conditions. 
Leukocytes, monocytes and macrophages are attached to the area of inflammation. 
They penetrate the blood-brain barrier near the tight junction region and form cuffs to 
get inside the perivascular space (Davoust et al. 2008, Abbott et al. 2010). 
1.4 Pathology in BBB 
Under healthy conditions the blood-brain barrier is highly permeable and acts as 
defense wall for toxic substances. Unfortunately, the permeability changes extremely 
under pathological conditions. Some chemicals mediate an increase of permeability 
that leads to an entrance of unwanted molecules into the brain. The wide range of 
barrier dysfunctions can range from mild or transient tight junction openings to 
chronic barrier breakdown which induce abnormalities in the molecular transport 
system cross the membrane (Abbott et al. 2010). Under hypertension, inflammatory 
mediated exposure of cytokines or leukocytes and ischemia conditions the BBB is 
obviously damaged in its structure (Moody 2006). The CNS is normally protected by 
their surrounding cells namely astrocytes, pericytes and microglia. Interestingly, 
under pathological circumstances these cells are able to enhance inflammation and 
trigger cellular damage. This process is mediated by modified regulation of 
neurotoxins and neurotropins (Ballabh et al 2003). In cases of a brain tumor the 
complete blood-brain function is disturbed. The down regulation of claudin-1 leads to 
the hypothesis that the molecule acts as an early marker in barrier dysfunctions 
(Liebner et al 2000). Also diseases such as multiple sclerosis (MS) or stroke are 
related to barrier break down and down regulation of claudin-1 and claudin-3. Shear 
stress has an influence on the expression of junctional compounds in endothelial 
cells especially in hypertension induced stroke (Wolburg and Lippoldt 2002). 
Changes in alternated nutrition transport through the membrane are caused by 
disruption of the blood-brain barrier. Often these abnormalities occur by changes in 
the metabolic system of the CNS (Banks 1999). In many times increased BBB 
permeability is an indication of pathology for example brain injury or stroke (Hawkins 
and Davis 2005). Neuro pathological studies showed that blood-brain barrier 
Page 20/ 93 
 
endothelial cells are protected from hypoxic stress through their surrounding cells like 
astrocytes and pericytes (Fischer et al 2002, Hayashi et al 2004). During drug abuse 
symptoms of dementia are amplified. Also the consumption of nicotine modifies the 
transport of ions which leads to an increase of the BBB permeability (Hawkins and 
Davis 2005). These events underline the great importance of studies with the aim to 
get more information about the connection between tight junction pattern and 
signaling processes in healthy versus disease circumstances (Wolburg and Lippoldt 
2002) 
1.5 Cell culture models for in vitro BBB experiments 
Lots of different cultivation models are presently available. The most common is the 
Transwell system in which mono- or co-culture in vitro experiments can be realized. 
In the early 90th Jochen Neuhaus and colleagues found out that astrocytes are 
mediators for the induction of BBB characteristics in brain endothelial cells. These 
observations could be shown by in vitro test models were bovine brain endothelial 
cells were co-cultured with astrocytes from rats. The cells were seeded in transfilter 
culture systems on both sides of the membrane but without direct contact between 
astroglial cells and bovine cells. In presence of astrocytes the permeability change of 
tight junctions were shown by a reduced sucrose penetration (Neuhaus et al. 1991). 
Another publication of Fred Arthur in the year 1987 exemplifies the effect of astrocyte 
conditioned media (ACM) on rat brain cells. The conclusion of this study was that 
ACM also induce tight junction formation in brain endothelial cells (Arthur et al. 1987). 
Astrocytes induce factors which influence the building up of tight junctions and their 
permeability. Both methods (ACM and co-culture) show efficient results to induce TJ 
formation in brain endothelial cells. Astrocytes are able to induce tight junction 
properties in endothelial cells, also if they are not of nervous system origin. 
Additionally, it is suggested that astroglial factors have to be highly conserved 
because their mechanism of action is not based on the same species from where the 
astrocytes were taken from (Janzer and Raff 1987). 
1.6 Proteomic approach 
Proteomics describes techniques and analyses of the whole proteome, which 
includes the entirety of proteins of one organism. There are several methods for 
proteome analyses. The most common fields for proteome research are the analysis 
of protein expression pattern, protein sequencing, protein identification and protein 
Page 21/ 93 
 
function assays. In this study the influence of different culture conditions on blood-
brain barrier cells was investigated using a classical proteome approach, including 2-
DE, tryptic in-gel digestion and subsequent MALDI-TOF MS. Further details about 
the used techniques are described in chapter [Materials and Methods]. 
1.6.1 What is the application of proteomics? 
The genetic code of an organism stays stable during its whole lifetime. Not all of the 
information present in the cellular genome will be expressed on the protein level. On 
the other hand the proteome pattern gives a more detailed insight in intracellular 
functions and mechanisms since the proteome is dynamic and underlies lots of 
structural changes. One gene can be transcribed into many proteins. Proteins exist in 
many forms and their functions are characterized by their modifications, which often 
define localization, structure and turnover number of proteins. By adapting the 
proteomic pattern an organism tries to cope with changing environmental conditions, 
which can be effects of biodiversity. Using mass spectrometry (MS) biomolecules, 
especially proteins and peptides can be detected. MS provides mass measurements 
of proteins up to 100 kDa and more. Furthermore, it is capable of identifying peptide 
masses after proteolytic digestion with high sensitivity. The sequence analyses of 
peptides, especially of species with less MS data availability, are of great importance. 
The results from mass measurements can be directly compared to sequence 
databases by the use of search engines to identify and characterize the proteins of 
interest. (Liebler 2002) 
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2 Aim of the work 
The dysfunction of the BBB has a major role in many diseases which is a hallmark 
for medical treatment. The properties of brain endothelial cells are strongly 
dependent on their surrounding cells which induce multiple factors, such as growth 
factors. These molecules have influence in the proper building of tight junctions which 
in turn are potential regulators of the brain permeability. Many BBB in vitro models 
exist and are more or less suitable to answer specific questions regarding brain 
pathology. Porcine brain endothelial cells (PBEC) are experimentally well established 
as in vitro models in human drug discovery research and are routinely used in clinical 
research. Nevertheless limited sequence data are available in protein databases 
about porcine endothelial cells. 
Main points of this pilot study are: 
 The cultivation of human primary cells (HUVEC) and immortalize porcine 
cells (PBMEC/C1-2) on Transwell filter systems  
 The identification of statistical results of changes in the proteome pattern by 
different cultivation conditions 
 The analysis of molecules of interests via 2D-DIGE 
 The detection of the significantly changed proteins via MALDI TOF MS 
 The indication of the biological function of the identified proteins 
 
The overall purpose of this project is the investigation of three different cell models 
(PBEC, HUVEC) in terms of how they are differently influenced by cultivation 
conditions using a proteomic approach. The main intension of this thesis is the 
observation of changes in the proteome pattern due to the following cultivation 
conditions (a) “uninduced system” (cultivation in respective growth media 
corresponding to the control), (b) “co-culture” (using a special experimental 
setup) and (c) “induced system” (culture in respective media including 
astroglial factors). Another aspect is the comparison of two different endothelial cell 
lines either of human or of porcine origin in terms of their suitability for proteomic 
investigations. In other words:  
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 Will it be possible to identify changes in the proteome pattern due to different 
cultivation conditions? 
 Are porcine BBB endothelial cells (PBEC) comparable with human endothelial 
cells (HUVEC) for the investigation of specific brain issues using proteome 
analysis? 
Obtained experimental results will be starting points for further detailed analyses to 
identify specific BBB target proteins. 
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3 Materials and Methods 
 
Materials 
3.1 Chemicals 
 
Amphotericin B, A2942 Sigma-Aldrich, Inc. (St. Louis, MO, USA) 
Bicarbonate, sterile, 7%, 25080, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
Bromophenol blue, Na salt, 15375, Serva Electrophoresis GmbH (Heidelberg, Germany) 
Bovine serum albumine BSA, A-8806, Sigma- Aldrich, Inc. (St. Louis, MO, USA) 
Calcium chloride solution, 1 M 21114, Sigma-Aldrich, Inc (St. Louis, MO, USA) 
Collagen bovine, 150703, MP Biomedicals (Irvine, CA, USA) 
Coomassie Brillant Blue G250 pure Serva Electrophoresis GmbH (Heidelberg, Germany) 
 
Dextran av. mol wt. 15.000-30.000, D 4626, Sigma-Aldrich, Inc. (St. Louis, MO, USA) 
DMEM (41966, plus 4.5 g/L glucose, L-glutamine and pyruvate; Gibco TM, Life Technologies, 
Carlsbad, CA, USA) 
DMSO, 1.02952.1000, MerckKGaA (Darmstadt, Germany) 
DTT research grade, 20710, Serva Electrophoresis GmbH (Heidelberg, Germany) 
Earle´s salt solution L1915 Biochrom (Berlin, Germany) 
EBM, CC-3156, Lonza Walkersville, Inc. (Walkersville, MD, USA) 
EDTA disodium, 11280, Serva Electrophoresis GmbH (Heidelberg,Germany) 
Ethanol 70% 
FCS, sterile, 10108-157, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
Fibronectin human, 356008, BD Biosciences (Bedford, MA, USA) 
Gelatine from bovine skin, Type B, G9391, Sigma-Aldrich, Inc. (St.Louis, MO, USA) 
Glycerol, 23176, Serva Electrophoresis GmbH (Heidelberg, Germany) 
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Glycine analytical grade 1kg, 23390, Serva Electrophoresis GmbH (Heidelberg, Germany) 
Ham´s F12, sterile, 21765-029, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
HBSS, 10x, sterile filtered, H4641, Sigma-Aldrich, Inc. (St. Louis, MO, USA) 
Heparin sodium salt from porcine intestinal mucosa, 51551, Fluka (Buchs, Switzerland) 
Hepes, 1 M, sterile, 15630-049, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
IMDM, sterile, 21980-032, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
 
Kanamycin (10 mg/ml) 15160-047, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, 
USA) 
L-Glutamine, 200 mM, sterile, 10x, 25030-024, Invitrogen Life technologies (Gibco TM, 
Carlsbad, CA, USA) 
M199, sterile, 31153-026, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
M199 sterile F0615 Biochrom (Berlin, Germany) 
Magnesium chloride solution, 1M, M1028 Sigma-Aldrich, Inc. (St. Louis, MO, USA) 
NCS, sterile, 26010-74, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
PBS, sterile, 14190-094, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
Penicillin/Streptomycin, 100x, sterile, 15140-122, Invitrogen Life technologies (Gibco TM, 
Carlsbad, CA, USA) 
Protease inhibitor cocktail, P8340, Sigma-Aldrich, Inc. (St. Louis, MO, USA) 
Puromycin A11138-03, Invitrogen Life technologies (Gibco TM, Carlsbad, CA, USA) 
 
TEMED research grade, 35925, Serva Electrophoresis GmbH (Heidelberg, Germany) 
Transferrin holo, for cell culture, T-0665, Sigma-Aldrich, Inc. (St. Louis, MO, USA) 
TRIS research grade, 37190, Serva Electrophoresis GmbH (Heidelberg, Germany) 
Triton X- 100 pure, 37240, Serva Electrophoresis GmbH (Heidelberg, Germany) 
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Trypsin/EDTA solution, 10x, sterile, 15400-054, Invitrogen Life technologies (Gibco TM, 
Carlsbad, CA, USA) 
Tween 20, 37470, Serva Electrophoresis GmbH (Heidelberg, Germany) 
 
3.2 Cell culture materials 
 
6- well Tissue Culture Plates,35046, BD Falcon (Franklin Lakes, NJ, USA) 
 
Cell culture inserts for 6-well plates, 353102, BD Falcon (Franklin Lakes, NJ, USA) 
 
Autoclave bags, 75x15 and 21x42, Schinko-Neuroth (Wolfsberg, Austria) 
Autoclave band, 84-200-048-CC, steam A, Schinko-Neuroth (Wolfsberg, Austria) 
Biofine tubing, ID 5mm, wall thickness 1 mm, Fresenius Medical Care (St. Wendel, Germany) 
Biofuge tubes, 15 ml, Cellstar 188271, Greiner Bio-One GmbH (Frickenhausen, Germany) 
Biofuge tubes, 50 ml, Cellstar 227261, Greiner Bio-One GmbH (Frickenhausen, Germany) 
Cell scraper, sterile, 541080, Greiner Bio-One GmbH (Frickenhausen, Germany) 
Eppendorf vials, Eppendorf AG (Hamburg, Germany) 
Eppendorf Reasearch pipettes, Eppendorf AG (Hamburg, Germany) 
Pipetman Pipette, 100 µl-1000 µl, 20 µl-200 µl, 1 µl-10 µl, 2 µl-20 µl, 0,2 µl-2 µl, Gilson 
(Middleton, USA) 
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Sterile filter flasks – Filtration System/Vacuum Driven GP Millpore Express (Billerica, MA, 
USA) 
Sterile pipette, Volume, 25 ml, 10 ml, 5 ml, 2 ml, Sarstedt Serological Pipette  
Tissue Culture Fasks, surface area 25 cm2, 75 cm2, 175 cm2, 690160, 658170, 660160, 
Greiner Bio-One GmbH (Frickenhausen, Germany) 
Thoma, counting chamber, Superior Marienfeld (Lauda-Königshofen, Germany) 
 
3.3 Proteome materials 
 
2-D Difference Gel Electrophoresis (2-D DIGE) 
DIGE Scanner  
Scanner Ettan DiGe Imager, GE Healthcare (Amersham, UK) 
Electrophoresis  
Ettan IPGphor 3, GE Healthcare (Amersham, UK)  
Ettan Dalt six, GE Healthcare (Amersham, UK)  
IPG strips, pI 3-11 non linear, GE Healthcare (Amersham,UK)  
IpGphor cup loading strip holders  
Labelling Kit, CyDye Dige, 25-8010-65, GE Healthcare (Amersham,UK) 
Software  
DeCycler 2D 7.0 
Two Dimensional Gel Electrophoresis (2-DE)  
BioRad - Protean II si Cell (Hercules, CA, USA)  
Ettan IPGphor 3, GE Healthcare (Amersham, UK)  
IPG strips, pI 3-11 non linear, GE Healthcare (Amersham,UK) 
MALDI TOF MS  
MALDI TOF/RTOF (AXIMA Tof2TM and CFR™) (Shimadzu Biotech Kratos Analytical, 
Manchester, UK) 
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Methods 
3.4 Cell culture 
3.5 Experimental cell lines 
Human umbilical vein cells (HUVEC)  
HUVEC are primary cells isolated from umbilical cords of newborns. The morphology 
of these cells is shown in figure 5. These cells were a kind gift from Dr. Renate Hofer-
Warbinek, Medical University Vienna. During the studies the cells were obtained 
directly after isolation. To enable the same conditions for the whole test, two cell 
doublings were conducted until the cells seeded on Transwell culture system with 
passage number 3. 
 
Figure 5: Characteristic cell structure of (untreated) human umbilical vein cells with spread 
cell branches. The cell body is clearly visible. The picture is adapted from Yang Jin Park et 
al. 2008. (In this graph (a) shows the control, untreated HUVEC). 
Porcine brain microvascular endothelial cells (PBMEC/C1-2)  
PBMEC/C1-2 are immortalized brain endothelial cells. Teifel and Friedel (1996) 
established and characterized these cells. The experimentally used PBMEC/C1-2 
cells to conduct this study were a kind gift of them.Many specific endothelial cell 
markers have been described, such as van Willebrand factor (vWF), lectin binding 
receptors for UEA-1, acetylated LDL as well as typical BBB properties. The picture 
[figure 6] shows the morphology of porcine brain endothelial cells with their stretched 
branches. Passage numbers up to more than 190 population doublings can be used 
without losing significant characteristics.. Immortalized PBMEC cells are well 
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appropriate for many cell doublings without losing specific characteristic properties up 
to passage 198 (Suda et al 2001). The highest passage number used in these 
studies was 79 including 35 cell doublings.  
Figure 6: Picture of a confluent cell layer with PBMEC/C1-2 cells. (Adapted from doctoral 
thesis, Winfried Neuhaus 2007) 
Primary porcine brain capillary endothelial cells (PBCECs) 
PBCECs are primary endothelial cells directly isolated from porcine brains. The 
isolation of capillary endothelial cells was done during a research stay at the 
University of Heidelberg.  
The morphology of primary porcine brain endothelial cells is comparable to that of 
PBMEC/C1-2. Under confluent conditions the cells have long stretched cell 
extensions without branches. The cell body is microscopically well observable. 
Rat glioma cells (C6) 
C6 cells are brain tumor cells from abnormal proliferating brain cells. They are 
isolated directly out of the rat brain. It is described that in most cases C6 cells are 
originally cancer stem cells1. Glioma cells were cultured to obtain astrocyte 
conditioned media (ACM) also named glioma conditioned media (GCM). Conditioned 
media was necessary for the cultivation experiments under induced conditions, 
where astrocytic factors inside the media have influence on the experimental cells to 
produce barrier properties. C6 glioma cells were received from Cancer Research 
                                                          
1
 http://cancerres.aacrjournals.org/content/67/8/3691.abstract (Accessed 16.03.2011) 
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Center Heidelberg. The used passage numbers of C6 rat glioma cells in these 
studies ranged from 21-33 cell doublings. 
Astroglial cells 
Astrocytes are glia cells located in the brain. They release factors which cause 
changes in the structure of endothelial cells. These properties are important for 
blood-brain barrier functions. In these test series astrocytic cells (which were a kind 
gift from Dr. Michael Berger, from Brain Research Center Vienna) were used for co-
cultivation tests. For experiments the astrocytes were taken from rat brain. The 
passage number normally ranges up to approximately ten cell doublings. During the 
study it could be observed that the passage number goes up to eight doublings with 
a loss of cells. The optimal density is reached between passage 0 and 10. After 
passage numbers ten or higher astrocytes needed more time to get confluent in 
comparison to cells with lower passage number. Therefore, in this study experiments 
were conducted with maximal five cell doublings. Working with primary cells requires 
experience in cell cultivation. 
 
The cell culture studies were conducted under aseptic conditions in the lamina air 
flow working bench. The following cell lines were used for cell culture experiments, 
except primary porcine capillary endothelial cells (PBCECs) which were gained by 
isolation studies during my research stay at University Heidelberg. Detail information 
about the main characteristics of those cells is explained in chapter 1.Introduction 
[1.6 Experimental cell lines]. 
1.  Human umbilical vein cells (HUVEC)  
2.  Porcine brain microvascular endothelial cells (PBMEC/C1-2)  
3.  Rat glioma cells (C6) 
4.  Astroglial cells 
 
Human umbilical cells and porcine brain microvasular cells were used for Transwell 
studies under every of the three different cultivation condition whereas rat glioma 
cells were taken to produce astroglial conditioned media (ACM). Astroglial cells were 
directly seeded at the bottom of each Transwell to conduct co-culture studies.  
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Sterile working conditions were ensured by using the laminar air flow working bench. 
All materials (sterile pipettes, tubes, media and solutions) were cleaned with Ethanol 
70% (v/v) before use. After finishing the daily tests the bench was cleaned with 
Ethanol 70% (v/v) and sterilized over night with ultraviolet radiation. 
Cell culture flasks had to be coated with sterile gelatine solution 1% (v/v). The volume 
of the coating solution is dependent on the flask size. In general for standardized 
tissue culture flasks T25 - 2 ml, for T 75 - 6 ml and for T175 - 10 ml of gelatine 
solution were taken to cover the surface area. After 25 min of incubation time in the 
incubator (37 °C, 5 % CO2 and 96% humidity) the gelatine solution was removed and 
the experimental cells could be seeded for growth into the culture flasks.  
3.5.1 Media and solutions 
For cell culture the following media and solutions were taken for the experiments. 
All media were sterile filtered inside the lamina air flow before usage. 
Trypsin/EDTA solution 
(For 200ml) 
20 ml 10x Trypsin/EDTA solution 
20 ml 10x HBSS 
154 ml sterile PBS 
2 ml 1 M HEPES 
2 ml 7.5 % (v/v) bicarbonate 
2 ml 10.000 Units/ml penicillin; 10 mg/ml streptomycin 
 
Cryomedium  
DMSO was added to sterile filtered NCS to reach a final concentration of 7 % (v/v).  
C6 medium 
C6 medium was used for cultivation of C6 cells and PBMEC/C1-2. The medium 
consists of a growth media mixture (ratio 1:1 of IMDM and Ham´s F12) and the 
following substances: 7.5 % (v/v) NCS, 7 mM L-glutamine, 5 µg/ml transferrin, 0.5 
U/ml heparin, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 µg/ml 
amphotericin B.  
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 (For 1000 ml)  
439 ml Ham´s F12 
439 ml IMDM 
35 ml 200 mM L-glutamine solution 
500 µl 10 mg/ml humane holo-transferrin 
500 µl 1000 U/ml heparin 
75 ml NCS 
10 ml 10.000 Units/ml penicillin; 10 mg/ml streptomycin 
1 ml 250 µg/ml amphotericin B 
 
Astrocyte conditioned medium (ACM) 
Astrocyte conditioned medium was gained from C6 glioma cells. The supernatant of 
growing cells was collected in sterile bottles (25 ml per day). 
PBMEC/C1-2 cell culture media 
At the beginning all PBMEC/C1-2 were cultured in C6 medium (see above). Those 
cells which were used for the cultivation condition (a) “not induced system” were 
further cultivated in C6 medium. Condition (b) “co-culture” was conducted in C6 
medium either. For experiments under condition (c) “induced system” cells were 
transferred to minus FIB medium (see below) which includes astroglial factors 
(ACM). In this thesis the terms minus FIB medium is used in the sense of astrocyte 
conditioned medium (ACM) without fibronectin.  
minus FIB medium (with astrocytic factors) 
Minus FIB medium consists of about 50 % C6 media and 50 % astrocyte conditioned 
media (ACM). Additionally, L-glutamine, holo-transferrin, heparin, penicillin, 
streptomycin and amphotericin B were added.  
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(For 500ml) 
104 ml Ham´s F12 
104 ml IMDM 
250 ml ACM (astrocyte conditioned media) 
17.5 ml 200 mM L-glutamine solution 
250 µl 10 mg/ml humane holo-transerine 
250 µl 1000 U/ml heparin 
19 ml NCS 
5 ml 10.000 Units/ml penicillin; 10 mg/ml streptomycin 
500 µl 250 µg/ml amphotericin B 
 
Cell shift from standard growth media to ACM for “induced culture test systems”: 
1st. day: 80 % standard growth media plus 20 % ACM 
2nd.day: 60 % standard growth media plus 40 % ACM 
3rd. day: 40 % standard growth media plus 60 % ACM 
4th. day: 100 % ACM 
 
HUVEC cell culture media 
The following media were used for cell culture  of human umbilical vein cells: Cells 
tested under conditions (a) “uninduced system” and (b) co-culture” have been 
cultured in basal endothelial medium without astrocytic factors, named EGM, 
whereas for condition (c) the “induced system” the conditioned medium minus EGM 
was used. 
EGM (Endothelia growth medium) 
The medium consists of a growth media mixture (ratio 1:1 of IMDM and EBM) and 
the following substances: 7.5 % (v/v) NCS, 7mM L-glutamine, 5 µg/ml transferrin, 0.5 
U/ml heparin, 100 U/ml penicillin, 100 µg/ml streptomycin and 0,25 µg/ml 
amphothericin B were added. 
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(For 1000 ml)  
439 ml EBM 
439 ml IMDM 
35 ml 200 mM L-glutamine solution 
500 µl 10 mg/ml humane holo-transerine 
500 µl 1000 U/ml heparin 
75 ml NCS 
10 ml 10.000 Units/ml penicillin; 10 mg/ml streptomycin 
1 ml 250 µg/ml amphotericin B 
 
Minus EGM (with astrocytic factors) 
Minus FIB medium consists of about 50 % C6 media and 50 % astrocyte conditioned 
medium (ACM). Additionally, L-glutamine, holo-transferrin, heparin, penicillin, 
streptomycin and amphotericin B were added.  
 (For 500ml) 
104 ml EBM 
104 ml IMDM 
250 ml ACM (astrocyte conditioned media) 
17, 5 ml 200 mM L-glutamine solution 
250 µl 10mg/ml humane holo-transferrin 
250 µl 1000 U/ml heparin 
19 ml NCS 
5 ml 10.000 Units/ml penicillin; 10 mg/ml streptomycin 
500 µl 250 µg/ml amphotericin B 
Media were changed every second day. Before changing the media the solutions 
were prewarmed at 37 °C for 30 min to avoid a temperature shock of cells. After 
removal of consumed media, fresh media were added. The volumes of added media 
depend on the size of tissue culture flask. Generally following volumes for media 
exchange have been taken: 
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Size of tissue culture flask Exchange volume 
T 25 5 ml 
T 75 10 ml 
T 175 25 ml 
 
Cell passaging 
Labeled flasks (name, date, passage number, cell line) were placed into an incubator 
(37°C, 5% CO2 and 96% humidity). Cells were checked in the microscope for 
confluence and adherence and passaged if necessary, around every 5 days. Old 
media were removed and the cells were washed twice with sterile PBS. Afterwards 
trypsin/EDTA solution (2 ml) was added. After morphological control under the 
microscope the trypsin/EDTA solution was removed and cells were detached from 
the surface. Cells were resuspended in fresh media and the required volume of the 
cell suspension depending on the splitting factor was transferred into a new cell 
culture flask, which had been coated with gelatine solution before. Usually the ratio of 
1: 10 (cell suspension to growth medium) was used. At the end the flask was filled up 
with 4.5 ml growth media and stored in the incubator.  
3.5.2 Cell freezing 
All cells were stored at -80°C prior to culture tests in order to expose them to similar 
conditions. After trypsinisation, 2 ml of cryomedium were added to one T 25 flask and 
the cell suspension was transferred into a cryotube. After 15 min incubation at +4°C 
the cells were stored in the freezer (- 80°C). 
3.5.3 Cell thawing 
Frozen cells in cryotubes were put into the water bath (37 °C) for a few seconds. 
When the melting process has started the whole solution is quickly put into 5 ml of 
prewarmed medium. The final cell solution was pipetted into a gelatin-coated T 25 
flask and stored in the incubator. On the following day medium was changed.  
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3.6 Transwell studies 
Transwell filter systems are common in vitro test methods to study the physiology of 
the blood-brain barrier. Today three different types of in vitro models are used in 
research: in silico models, the Transwell model and the dynamic in vitro model of the 
blood-brain barrier. The advantages of the Transwell model are easy handling, the 
possibility to conduct multiple tests at the same time, low acquisition costs, and the 
possibility to perform transport experiments (Cucullo et al. 2005). These transport 
studies are conducted on Transwell filter systems [figure 9 and figure 10].  
 
2 Figure 9: The picture shows the mechanism of inserts inside the Transwell plate. The blue 
framed line shows the insert, which is submerged in medium. On the bottom of the insert is a 
porous membrane where cells are grown.  
    
3
Figure 10: The whole 6-well Tissue Culture model is demonstrated on the left side. On the 
right side a single insert is shown. The insert will be put inside the well of the plate as 
described in figure 9. 
The Transwell model consists of the 6-well tissue culture plate and appropriate 
inserts. The insert is placed into the well which is filled up with growth medium. The 
                                                          
2
 http://catalog2.corning.com/Lifesciences/media/pdf/transwell_guide.pdf (Accessed 16.03.2011) 
3
 http://catalog.bd.com/bdCat/viewProduct.doCustomer?productNumber=353046 (Accessed 
18.03.2011) http://www.ultident.com/scientific/categories.php?category=Cell-and-Tissue-Culture/Cell-
Culture-Inserts-and-Companion-Plates (Accessed 18.03.2011) 
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model is divided in two separated compartments. The inserts represent the donor 
chamber (upper compartment) whereas the well acts as acceptor chamber (lower 
compartment). The upper area inside the insert represents the lumen of brain 
microvessels and the surrounding as lower compartment represents the brain. The 
main characteristics of that model are the side by side diffusion effect through the 
porous semi-permeable insert membrane. The growing area at the bottom of the 
insert is 4.2 cm2 and the membrane pore size is 1 µm which is close enough to 
prevent cell migration.  
3.6.1 Coating of the Transwell insert 
The coating procedure was done under the laminar air flow cabinet. The inserts were 
put in the 6-well plate with sterilized forceps. Each insert was filled with 150 µl of 
sterile collagen solution at the concentration of 0.14 mg/ml. After one hour storage in 
the incubator the collagen supernatant was removed and the plate was dried for 15 
min before 150 µl fibronectin solution were added into the insert. Again a one hour 
incubation step followed and subsequently the supernatant was removed from each 
insert.  
3.6.2 Cell seeding 
In this study three different types of cultivation methods were used, namely (a) the 
“uninduced system”, (b) the co-culture and (c) the “induced system”. They are divided 
in monoculture (a) and (c) and co-culture (b) seeding conditions. The “uninduced 
system” consisted of one experimental cell line which was seeded directly on the 
coated insert membrane. The “induced system” and the “uninduced system” have the 
same seeding conditions and are monocultures. The “co-culture system” consists of 
the experimental cell line at the membrane surface but in addition on the well surface 
a confluent layer of astrocytes is grown. The seeding density of astrocytes was 
chosen with 60.000 cells/cm2 per well. This type of co-culture system is named non 
direct contact co-culture because astrocytes were not seeded on the lower insert 
membrane area. 
Generally cells were seeded on Transwell filter inserts with a density of 80.000 
cells/cm2. The cell number was determined in a Thoma chamber. The chamber was 
filled with 12 µl cell suspension and cells were counted under the light microscope. 
The average number was multiplied by 104 to calculate the cell number per ml. In 
general one well was filled up with 3 ml of preheated growth media and inside the 
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insert 2 ml of the prepared cell suspension was added. The plate was labeled and 
stored in the incubator (37 °C, 5% CO2 and 96% humidity). Four wells per plate were 
used with test cells (probe) and the two remaining were used for controls (blank). In 
the following scheme [figure 11] the well classification between probe and blank is 
shown. 
 
Firgure 11: The graphic represents the setup of the Transwell experiments: Well number 1 
to 4 contained cells whereas well 5 and 6 were only filled with media  
The coated Transwell inserts with number 5 and 6 were used as standards (blank).  
3.6.3 Media exchange on Transwell model 
Regular medium exchange is necessary for the cell cultivation inside the Transwell 
model. The culture medium was changed every day. Cell growth was controlled daily 
in the light microscope and in parallel TEER measurements were conducted [see 
3.5.4 TEER measurements]. All plate inserts were picked with sterile forceps and the 
consumed medium was removed. During the medium removal from the plate, inserts 
were placed into an empty 6-well. Afterwards 3 ml of fresh medium were added into 
each plate well and 2 ml of fresh medium were placed in each insert. The labeled 
plate was placed back into the incubator.  
3.6.4 Transendothelial Electrical Resistance (TEER) measurements 
TEER was controlled by Millipore Millicell Electrical Resistance system (ERS) which 
is pictured in figure 12.  
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4 Figure 12: This pictures shows an ERS voltmeter for TEER measurement 
Two electrodes are connected with the voltmeter which displays the measured 
resistance of the Transwell system: a shorter one for the insert and a longer one for 
the well. Both electrodes were equilibrated for 30 min in prewarmed media before 
use. Afterwards they were placed directly into the media for TEER record, whereby 
the steadying of the electrodes was a critical issue. In between every record the 
electrode was cleaned with ethanol. The resistance is inversely proportional to the 
cell permeability. TEER values were calculated by the formula that derives from 
Ohm´s law.  
TEER [Ωxcm2] = (TEERcell – average TEERblank) x surface area (4, 2 cm
2) 
Cell lysis was performed in case the measured value was about +/- 20 Ωxcm2 or 
higher and furthermore if density observation by light microscope showed a highly 
confluent cell layer.  
3.7 Cell lysis 
Lysis buffer 
8 M Urea  
2 M Thiourea   
0.5 % Trition X-100  
2 % Chaps  
5 mM EDTA 
Before use 2 mg DTT and 4 µl protease inhibitor cocktail were added to each aliquot 
of 500 µl lysis buffer. The whole cell lysis was done outside the lamina flow cabinet 
                                                          
4
 http://www.reiss-laborbedarf.de/uploaded/image/shop/millipore/MB330-06%5b1452-ALL%5d_big.jpg 
(Accessed from 14.03.2011) 
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but cooled on ice. The medium was removed from the inserts and each insert was 
washed twice with PBS. PBS was removed carefully to prevent any dilution. The cell 
monolayer of one insert was incubated with 50 µl lysis buffer for 3 min on ice. For cell 
lysis in cell culture flasks 200 µl of lysis buffer were used. Cells were scraped and the 
lysate was transferred into Eppendorf tubes and centrifuged at 12.000 rpm for 10 
min. The supernatants were stored at -80 °C until they were used for protein 
analysis. 
3.8 Bradford assay 
Bradford solution 
(For 100 ml)  
10 mg (0.01 %) Coomassie Brillant Blue G250  
5 ml (5 %) Ethanol, 96 %  
10 ml (10 %) H3PO4 , 85 % (v/v)  
85 ml H2O bidest.  
Determination of protein concentrations was performed by the Bradford assay 
(Bradford 1976). Protein samples and BSA standards (1 mg/ml) were mixed with 
Bradford solution and after five minutes incubation time at room temperature (RT) 
extinctions were measured at 595 nm. Protein concentrations were determined using 
a BSA calibration curve (0.025, 0.05 and 0.1 mg BSA/ml) which was performed for 
every measurement. If necessary samples were diluted with H2O bidest. to receive a 
value within the linear range of BSA (0.2 to 0.7 mg/ml).  
3.9 DIGE 2D-Electrophoresis 
DIGE solutions 
Labeling 
 Standard cell wash buffer, 10 mM Tris (pH 8,0), 5 mM magnesium acetate. Stored in 
aliquots at -15°C to -30°C. 
 Lysis buffer, 30 mM Tris base, 7M urea, 2 M thiourea, 4 % (w/v) CHAPS 
 Lysine, 10 mM L-lysine 
 pH indicator strips (GE Healthcare) 
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Sample buffer (2x) 
8M Urea  
130 mM DTT  
4 % (w/v) CHAPS  
2 % (v/v) Pharmalyte TM 3-10 NL for IEF 
Rehydration buffer 
8 M Urea  
4 % (w/v) CHAPS  
1 % (v/v) Pharmalyte TM 3-10 NL for IEF  
13 mM NaOH 
Sodium Hydroxide 
50 mM NaOH 
Gel loading buffer (2x) 
120 mM tris (pH 6.8)  
20 % (v/v) (87 % glycerol, 4% SDS 200 mM DTT and a few grains of bromophenol blue) 
12.5 % Acrylamide gel 
40 % acrylamide/bis-acrylamide  
25 ml tris (1.5 M)  
1 ml SDS 10 % (v/v)  
1 ml ammonium persulfate 10 % (w/v)  
40 ml TEMED  
(make up to 100 ml with H2O bidest.) 
SDS electrophoresis running buffer (1x) 
25 mM tris  
192 mM glycine  
0.2 % SDS 
Two dimensional difference gel electrophoresis (2D-DIGE) was used for quantitative 
proteomics. In this method the proteins are labeled with fluorescence dye markers 
(CyDye DIGE Fluors). This technique makes it possible to separate up to three 
different protein samples on one 2-D gel. The internal standard was labeled with Cy2 
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(yellow) whereas protein samples were labeled with Cy3 (red) and Cy5 (blue) 
according to the manufacturer`s instructions (Product Booklet for Ettan Dige,  
Ge Healthcare). 
25 µg of each labeled sample (Cy3, Cy5) and 25 µg of the internal standard (Cy2) 
were diluted with rehydration buffer to a total volume of 350 µl. For the first 
dimension, isoelectric focusing (IEF) was performed on 18 cm, non linear IPG strips 
with a pI range from 3-11. The rehydration step was performed for 12 h at 20 °C and 
IEF was carried out to a total of 80 kVhr (Stessl et al. 2009).  
The CyDye Fluors bind covalently to the epsilon amino group of lysine due to their 
reactive NHS ester group. Minimal labeling was used, meaning that only 1-2% of 
sample proteins were labeled with the respective dyes. The IPG strip was placed on 
a homogenous 12.5 % polyacrylamide gel. The proteins were separated at a 
constant voltage of 50 mA per gel in the second dimension. 
DIGE Scan was performed with an Ettan Dige Imager at 100 µm resolution. The 
evaluation was conducted with the software program DeCycler version 7.0. Gels were 
grouped (not induced, induced and co-culture group) and analyses with the Batch 
program. Proteins of interest were defined using teh following grogram settings: 
exclusion filter for differential in gel analysis (DIA) (slope: > 1.7, volume: minimum 
50.000, peak height: 0 to 10.000). Subsequently gels were matched and proteins of 
interests were defined meeting the following statistical conditions: average ratio +/- 
1.5, Student’s t-test (ρ < 0.05) and presence in at least 9 of 12 spot maps. 
3.10 2-D Electrophoresis 
IEF 
IEF was performed as described above without CyDye labelling. 
SDS-PAGE 
Gel preparation 
Separation buffer (4x) 
90.8 g tris (1.5 M)  
2 g SDS (0.4 % (w/v)) 
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Acrylamide solution (30.8 %, 37.5:1) 
120 g acrylamide (30 % (w/v))  
3.2 g N,N´ -methylenebisacrylamide (0.8 % (w/v)) 
12.5 % separation gel 
11.86 ml H2O bidest  
8.75 ml separation buffer (4x)  
14.2 ml acrylamide solution (30.8 %)  
21.88 µl TEMED  
164 µl APS (10 %) 
Stacking gel buffer (4x) 
6.06 g tris (0,5 M)  
0.4 g SDS (0.4 % (w/v)) 
Stacking gel 
3 ml H2O bidest   
1.25 ml stacking gel buffer (4x)  
0.65 ml acrylamide solution  
5 µl TEMED  
50 µl APS (10 %) 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-Page) is an 
important method for protein analysis to separate proteins within a gel matrix in an 
electrical field according to their molecular weight. Proteins are denaturated and 
saturated with negatively charged SDS in order to avoid separation by charge. 
Dependent on their molecular weight proteins are separated. The gel matrix in this 
study consists of polyacrylamide. The whole gel was divided in two parts: - the 
stacking gel which provides a simultaneous start of proteins, and the separation gel, 
where the ultimate separation takes place. The appropriate diluted protein extract 
was reduced by dithiothreitol (DTT) and separated on 12. 5 % gel. Gels were silver 
stained according to the following staining protocol.  
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Silver staining (MS compatible) 
The silver staining was processed according to Blum´s staining protocol (Blum 1987). 
Following solutions were used to incubate the gels for different time periods. During 
this method ethanol 30 % (v/v) was taken for washing steps after the fixation step.  
Fixing solution 
30 % acetic acid  
40 % methanol 
Wash ethanol 
30 % ethanol 
Sensitizer solution 
6.8 g sodium acetate  
0.2 g Na2S2O3 
Silver solution 
0.5 g silver nitrate  
50 µl formaldehyde  
Developing solution 
30 g Na2CO3  
5 mg Na2S2O3  
500 µl formaldehyd 
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Staining protocol 
Fixing 1 hour   
Washing with EtOH (30 %) 2 x each 20 min  
Washing with MilliQ 20 min  
Sensitizing 1 min  
Washing with Aqua dest. 3 x each 1 min  
Silver staining 20 min  
Washing with Aqua dest. 3 x each 1 min  
Developing 2 min  
Washing with Aqua dest. 3 x each 1 min 
Gels were kept in Aqua dest. until MS analysis 
3.11 Tryptical in-gel digestion 
Solutions 
ABC buffer 
100 mM NH4HCO3 buffer 
Destaining solution 
Na2S2O3
 (100 mM)  
K3[Fe(CN]6] (30 mM) 
Mixture 1:1 
Reducing solution 
10 mM DTT dissolved in 100 mM NH4HCO3 (ABC)  
Alkylating solution 
54 mM iodoacetamide dissolved in 100 mM NH4HCO3 (ABC) 
In-gel digestion was conducted with the defined proteins of interests (POI). Protein 
spots for MS analysis were cut out from the gel by a scalpel and each piece was 
transferred into an Eppendorf tube which was filled up with bidest. H2O. A matrix 
piece from blank gel regions acted as “control” spot to identify MS peaks deriving 
from the gel matrix. Gel spots were destained with destaining solution carefully 
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washed with MilliQ and 100 % acetonitrile (ACN) solution. Then they were reduced 
with 10 mM dithiothreitol in reducing solution for 40 minutes at 56 °C, afterwards 
washed twice with washing buffer and alkylated with 54 mM iodoacetamide in 
alkylation solution for 20 min at 20 °C in the dark. Two washing steps followed before 
gel pieces were dried in a vacuum centrifuge for 15 min. In-gel digestion was 
performed in the microwave for 10 min at 170 W with trypsin (Roche, 
Mannheim,Germany; 12.5 ng trypsin per µl) . Peptides were extracted from gel 
pieces by three extraction steps with each 40 µl of ABC buffer, ABC buffer/ ACN and 
0.1 % trifluoroacetic acid (TFA)/ACN. The supernatants were frozen over night and 
dried on the next day in the vacuum centrifuge at 37 °C.  
Peptides were desalted by Zip-Tip purification using Zip Tips C18 (Millipore, Bedford, 
MA, USA) according to the Millipore product protocol. α-Cyano-4-hydroxycinnamic 
acid (Sigma Aldrich) was used as MALDI matrix and samples were prepared using 
the dried droplet method. 
3.12 MALDI TOF MS 
The identification of proteins was measured in positive ion mode on a MALDI 
TOF/RTOF (AXIMA Tof2TM and CFR™, respectively) (Shimadzu Biotech Kratos 
Analytical, Manchester, UK) using a CHCA (α-cyano-4-hydroxycinnamic acid) matrix. 
Calibration was conducted with a peptide mix which includes singly charged 
monoisotopic m/z values of standard peptides (Stessl et al. 2009). PMF spectra were 
evaluated by mMass software (Version 3.105) (Strohalm 2010, Strohalm 2008). 
Keratin, matrix peaks or peaks caused by tryptic auto-digestion were identified 
separately (Mattow J 2004, Smirnov IP 2004) and excluded from spectra. Protein 
identification was performed via the public search engine Matrix Science-Mascot 
(Peptide Mass Fingerprint, Version 2.3.02). Following databases were used during 
data analysis (NCBInr and SwissProt (Version 56.0) August 2010 –December 2010). 
Search criteria were defined as follows:fixed modifications (carbamidomethylation of 
cysteins), variable modifications (oxidation of methionins), taxonomy (mammalia), 
missed tryptic cleavages (1), peptide tolerance (+/- 0.5 –0.2 Da). 
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3.13 Isolation of primary PBCECs 
The process to isolate primary porcine brain endothelial cells out of the brain was 
lerned during a research stay at the Department for Pharmaceutical Technology and 
Biotechnology, University Heidelberg. Briefly, the process is divided into five steps 
which are shown in the overview picture (figure 14).  
Step 1: Brain acquisition and Cortex preparation 
Step 2: Capillary isolation 
Step 3: Capillary separation 
Step 4: Cell isolation 
 
 
Figure 14: This picture shows an overview of the isolation procedure, separated into five 
steps. Step one is the brain acquisition and cortex preparation, step two the capillary 
isolation, step three the capillary separation and finally the cell isolation. (Helm 2010) 
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4 Results 
Within this study the porcine BBB cell line PBEC/C1-2 (porcine brain endothelial 
cells) and HUVECs (primary human umbilical vein endothelial cells) were cultured 
onto 6 Well tissue culture plates. To determine whether soluble factors secreted by 
astrocytes lead to changes in barrier formation and proteome pattern, both cell lines 
were cultivated in standard growth medium ,in medium enriched with glioma derived 
soluble factors, or in the presence of rat astrocytes  
4.1 TEER measurements 
Before cell lysis and subsequent proteomic studies, the cell density was assessed by 
measuring the transendothelial electrical resistance (TEER).  
The calculation of the electrical resistance was based on the following formula: 
TEER [Ωxcm2] = (TEERcell – average TEERblank) x surface area (4, 2 cm
2) 
The definition of the probe number was according to the scheme in chapter 3.5.2 Cell 
seeding (figure 11). 
The PBMEC/C1-2 cell measurements were conducted three or four days after cell 
seeding (cs), until a dense cell monolayer could be observed under the microscope. 
The electrical resistance measurements for HUVEC were done at the following day 
after cell seeding and the day before cell lysis. Interestingly, the average cultivation 
time period from seeding to cell lysis differed between PBMEC/C-1 and HUVEC up to 
one or two days. 
The measured TEER results are listed in the tables above: 
PBMEC/C1-2 (uninduced in C6 medium)  
3rd day after cell seeding (cs) 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 134 137 -12.6 
3 134 137 -12.6 
2 135 137 -8.4 
1 138 137 4.2 
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PBMEC/C1-2 (cultivated in - FIB medium)  
3rd day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 133 136 -12.6 
3 119 136 -71.4 
2 134 136 -8.4 
1 136 136 0.0 
  
 
 
* no significant TEER values - whiskers 
 
 
 
 
 
*no significant TEER values – whiskers 
 
HUVEC (uninduced in EGM medium) A1 
 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 139 143.5  -18.9 
3 141 143.5  -10.5 
2 141 143.5  -10.5 
1 137 143.5  -27.3 
*Control measurement to check the electrode function 
PBMEC/C1-2 (co-culture in C6 medium)  
4th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 620 648 -117.6 
3 628 648 -84.0 
2 624 648 -100.8 
1 614 648 -142.8 
PBMEC/C1-2 (co-culture in C6 medium)  
4thday after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 411 350 256.2 
3 382 350 134.4 
2 352 350 8.4 
1 379 350 121.8 
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HUVEC (uninduced in EGM medium) PL1 
1st day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 130 131 - 4.2 
3 128 131 -12.6 
2 133 131 8.4 
1 132 131 4.2 
 
HUVEC (uninduced in EGM medium) PL2 
1st day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 133 129 16.8 
3 131 129 8.4 
2 135 129 25.2 
1 134 129 21.0 
 
HUVEC (uninduced in EGM medium) PL1 
3rd day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 125 119.5 23.1 
3 115 119.5 -18.9 
2 124 119.5  18.9 
1 123 119.5  14.7 
 
HUVEC (uninduced in EGM medium) PL2 
3rd day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 123 120 12.6 
3 118 120 -8.4 
2 127 120 29.4 
1 122 120 8.4 
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HUVEC (uninduced in EGM medium) PL1 
4th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 138 119.5 77.7 
3 132 119.5 52.5 
2 139 119.5 81.9 
1 144 119.5 102.9 
 
HUVEC (uninduced in EGM medium) PL2 
4th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 119 111 33.4 
3 112 111 4.2 
2 117 111 25.2 
1 110 111 -4.2 
 
HUVEC (co-culture in EGM medium) PL1 
1st day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 95 96 -4.2 
3 96 96 0.0 
2 98 96 8.4 
1 110 96 58.8 
 
HUVEC (co-culture in EGM medium) PL2 
1st day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 107 102.5 18.9 
3 112 102.5 39.9 
2 107 102.5 18.9 
1 115 102.5 52.5 
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HUVEC (co-culture in EGM medium) PL1 
4th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 87 83 16.8 
3 97 83 58.8 
2 120 83 155.4 
1 90 83 29.4 
 
HUVEC (co-culture in EGM medium) PL2 
4th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 95 105 -42.0 
3 96 105 -37.8 
2 98 105 -29.4 
1 110 105 58.8 
 
HUVEC (induced in - EGM medium) PL1 
5th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 135 122 54.6 
3 127 122 21.0 
2 126 122 16.8 
1 123 122 4.2 
 
HUVEC (induced in - EGM medium) PL2 
5th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 136 125.5 44.1 
3 140 125.5 60.9 
2 139 125.5 56.7 
1 135 125.5 39.9 
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HUVEC (induced in - EGM medium) PL3 
5th day after cs 
Probe 
number Value Probe 
Av. value 
blank TEER [Ωxcm2] 
4 139 125.5 56.7 
3 139 125.5 56.7 
2 134 125.5 35.7 
1 139 125.5 56.7 
 
The values of the TEER measurements show variations between the probe numbers. 
In parallel the tissue culture plates were checked daily after the first day from seeding 
the cells until lysis. The visual observation of the cell layer was an important control 
parameter beside the TEER measurements. 
Experimentally observed time period (days) from cell seeding to cell lysis: 
 PBMEC/C1-2 HUVEC 
 Duration in days 
Uninduced 4 5 
Induced 3 6 
Co-culture 4 5 
Table 1: Cultivation time period of PBMEC/C1-2 and HUVECs 
 
The results in Table 1 display differences in the period of cultivation between the two 
experimental cell lines (PBMEC/C1-2, HUVEC). Noticeable variation could be 
determined for induced system, where the cultivation days are doubled between 
PBMEC/C1-2 and HUVEC.  
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Standard variation of TEER values before cell lysis: 
 
Figure 15: Diagram from standard variation of TEER values at the day before cell lysis. The 
co-culture values of PBMEC are not significant (whiskers) and have not been considered for 
the statistic calculation. 
 
Generally, HUVECs formed a tight cell monolayer regardless of the culturing 
conditions, as indicated by TEER increase after four days. No significant changes 
between the different cultivating conditions were detected. The comparison of the 
time period after cell seeding (cs) and cell lyse differ from HUVEC to PBMEC/C-1. 
The cultivation period in tranwell filter system of PBMEC/C1-2 cells were maximum 
four days. PBMEC/C1-2 co-culture system and uninduced system took four days for 
cultivation whereas cells from the induced system were lysed after three days. 
Interestingly, HUVEC cells were cultivated for about five days in transwell culture 
plates. Both the co-culture system and the uninduced system were cultivated for five 
days while the induced system took for six days before the cells could be lysed. 
Summarizing, no significant changes inside the different cultivation conditions were 
determined by contrast different duration of the cultivation time between PBMEC/C1-
2 and HUVEC were observed, especially for co-culture system. 
uninduced induced co-culture
PBMEC -23,1 -26,6
HUVEC 46,7 42 26,2
-80
-60
-40
-20
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4.2 Proteomics 
After confirming by TEER measurements and visual inspection that a tight and stable 
monolayer had been formed, cells were lysed for the proteome analysis. The different 
culture conditions were done in triplicates (uninduced, induced and co-culture).The 
proteomic analyses were conducted using 2D DIGE and protein identification was 
performed via MALDI TOF MS. Typical gels of PBMEC/C1-2 and HUVECs are 
depicted in the following chapter (4.2.1 Comparison of PBMEC/C1-2 and HUVEC). 
4.2.1 Comparison of PBMEC/C1-2 and HUVEC  
All experiments were conducted under the same conditions inside the Transwell filter 
systems. The first comparison was done among uninduced models. That means the 
cells were cultivated in growth medium without any blood-brain barrier (BBB) 
inducing factors. 
Uninduced cultivation models 
(75µg per gel, pI 3-11, 12.5% gel) 
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Figure 15: Representative 2D gels of human umbilical vein cells (HUVEC) and porcine brain 
microvessel endothelial cells (PBMEC/C1-2) are shown in picture a) and b). The l cells were 
grown in basal growth medium (C6 or EGM) without any blood brain barrier (BBB) properties 
including agents. 
 
Induced cultivation models 
During these experiments, cells were cultivated in medium that includes astrocyte 
growth factors (ACM) with the aim to induce typical BBB function in endothelial cell. 
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Figure 16: Picture c) and d) shows the proteome pattern of induced PBMEC/C1-2 and 
HUVEC cells. Additionally proteins of interests are marked in orange. (75µg per gel, pI 3-11, 
12. 5% gel) 
 
Co-culture models 
These cultivation studies included a non directly contact co-culture system with 
astrocyte cells from rat brains. Astrocyte conditioned medium induce BBB factors into 
endothelial cells leading to changes in the tight junction structure of endothelial cells.  
 
Page 58/ 93 
 
 
Figure 17: The proteome pattern of picture e) and f) shows the separated proteins of 
PBMEC/C1-2 cells and HUVEC cells after cultivation in media enriched with astrocytes. 
(75µg per gel, pI 3-11, 12.5% gel)  
Protein list of significantly changed proteins 
The remarkable changed proteins (POI) were labeled and listed according to their 
Master ID number. In the following pictures the significantly changed proteins from 
HUVEC and PBMEC/C1-2 in co-culture transwell filter system are demonstrated. 
Decyder software version 7.0 was used to identify significantly changed protein spots 
with a minimum change of 1.5 fold, and statistical significance reflected by a t-test 
value of 0.05 or lower, all compared to the untreated control cohort. Table 1,2 shows 
protein spots differentially regulated in PBMEC/C1-2 cells, and table 3,4 those of 
HUVECs. Approximately forty spots of PBMEC/C1-2 were found to be up- or down 
regulated after induction with astrocyte conditioned medium and more than thirty 
spots after co-culturing with rat astrocytes. Fewer spots (about six after treatment 
with conditioned medium, more than twelve after the co-culture) were differentially 
regulated in HUVECs 
.  
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Porcine brain microvessel endothelial cells (PBMEC/C1-2) 
 
Figure 16: 2D gel image of significantly changed proteins from PBMEC/C1-2 in co-culture 
transwell filter system. (pI 3 -11 NL, 12.5 % SDS-Page, silver stained) The labeled proteins 
with their Master number are listed according to statistical parameters in the following table 
(Protein list: PBMEC/C1-2: Co-Culture versus ACM). 
 
Protein list: PBMEC/C1-2: Co-Culture ACM versus uninduced system 
Table of remarkable changed proteins of PBMEC/C1-2 with statistically parameters 
(t-value, Av. Ratio) from co-culture and induced (ACM) systems versus the 
uninduced system. 
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Table 1: Values of changed protein spots of co-culture and induced (ACM) system compared 
to uninduced system. (X= the value does not lie inside the parameter area – no significant 
change detected) 
 Co-culture ACM 
Master No. T-test Av. Ratio T-test Av.Ratio 
208 X X 0,022 2,49 
288 X X 0,045 2,86 
452 0.052 -1.80 0,0099 -2,72 
525 X X 0,0043 -3,42 
532 X X 0,046 -5,75 
541 X X 0,0055 -4,98 
564 0.096 -2.25 0,028 -3,15 
565 0.090 -2.15 0,018 -4,12 
568 0.014 -2.03 0,0075 -3,64 
570 0.029 -2.60 0,039 -2,84 
575 X X 0,0038 -3,38 
578 0.20 -1.72 0,034 -4,97 
580 X X 0,033 -4,5 
587 0.0091 -2.87 0,021 -2,95 
592 0.20 -1.79 0,048 -4,57 
594 X X 0,018 -3,49 
595 0.0033 -2.48 0,0021 -3,68 
612 0.042 -2.51 0,023 -2,6 
679 0.093 -1.51 0,0073 -3,71 
684 0.22 -1.48 0,037 -4,15 
692 0.087 -1.60 0,0086 -2,92 
742 X X 0,018 -3,47 
847 0.26 -1.37 0,034 -2,34 
864 X X 0,044 -2,81 
888 0.20 -1.52 0,042 -2,83 
1077 0.0015 -2.22 5,50E-05 -3,03 
1098 0.031 -1.84 0,0028 -2,52 
1100 0.0088 -1.96 0,00028 -2,94 
1202 X X 0,038 2,14 
1493 0.042 -2.27 0,0076 4,77 
1508 X X 0,02 1,71 
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Co-Culture and ACM 
Master No. T-test Av. Ratio 
452 0,008 -2,26 
470 0,034 -2,03 
481 0,012 -2,3 
528 0,039 -2,43 
535 0,036 -3,62 
541 0,03 -3,31 
560 0,042 -1,54 
561 0,027 -2,59 
563 0,047 -2,45 
564 0,011 -2,7 
565 0,012 -3,14 
568 0,0049 -2,83 
570 0,0047 -2,72 
572 0,008 -3,06 
575 0,0092 -2,89 
578 0,04 -3,35 
580 0,033 -3,19 
587 0,0015 -2,91 
592 0,043 -3,18 
594 0,016 -3,01 
595 0,00052 -3,08 
596 0,013 -2,36 
612 0,0048 -2,56 
613 0,036 -2,52 
623 0,0084 -2,08 
646 0,04 -2,46 
650 0,039 -2,31 
663 0,038 -2,11 
679 0,031 -2,61 
692 0,014 -2,26 
847 0,042 -1,86 
888 0,047 -2,17 
1077 0,00017 -2,63 
1098 0,0032 -2,18 
1100 0,0013 -2,45 
1159 0,05 1,54 
 
Table 2: Table of significant changed proteins of PBMEC/C1-2,co-culture and induced 
system together versus uninduced system. 
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Human umbilical vein endothelial cell (HUVEC) 
 
Figure 17: 2D gel image of significantly changed proteins from HUVEC in co-culture 
transwell filter system (pI 3 -11 NL, 12.5 % SDS-Page, silver stained).The labeled proteins 
with their Master number are listed according to statistical parameters in the following table 
(Protein list: HUVEC: Co-Culture versus ACM). 
 
Protein list: HUVEC: Co-Culture and ACM versus uninduced system 
 Co-culture ACM 
Master 
No. 
 
T-test 
 
Av. Ratio 
 
T-test 
 
Av. Ratio 
49 0.028 -8.15 X X 
166 0.028 -6.02 X X 
176 0.044 -4.27 X X 
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Master 
No. 
 
T-test 
 
Av. Ratio 
 
T-test 
 
Av. Ratio 
209 0.027 -6.55 X X 
214 0.032 -9.47 X X 
224 0.038 -9.61 X X 
243 0.040 -12.48 X X 
367 X X 0.018 -2.77 
387 0.044 -4.25 X X 
498 0.023 -1.68 X X 
535 X X 0.030 3.37 
626 X X 0.017 2.89 
628 X X 0.0059 -9.73 
639 0.041 2.90 0.032 -1.76 
669 0.028 -5.72 X X 
703 X X 0.0062 3.41 
720 0.038 -3.93 X X 
733 X X 0.034 4.87 
795 0.036 -3.31 X X 
809 0.034 -6.76 X X 
837 X X 0.039 4.09 
906 X X 0.024 4.78 
979 0.036 4.12 0.029 -1.80 
1018 X X 0.009 5.01 
1419 0.025 -5.44 X X 
 
Table 3: Spot intensity values of changed proteins from HUVECs. Spots of co-culture and 
induced (ACM) system compared with uninduced system. (X= the value does not lie inside 
the parameter area – no significant change detected) 
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Co-culture and ACM 
Master No. T-test Av. Ratio 
49 0.0096 -9.15 
98 0.025 -6.43 
208 0.045 -9.28 
209 0.0078 -6.52 
214 0.0097 -9.98 
224 0.014 -11.05 
243 0.013 -12.20 
303 0.026 -5.87 
348 0.028 -3.81 
574 0.049 -1.91 
617 0.031 -8.24 
628 0.029 -6.01 
639 0.048 -9.72 
979 0.036 -8.64 
1273 0.046 -12.75 
1276 0.031 -13.45 
1018 0.025 -5.32 
1419 0.038 -3.72 
 
Table 4: Table of significant changed proteins from HUVEC, co-culture and induced 
system together versus uninduced system. 
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MALDI TOF identification 
Proteins of interest were identified by MALDI TOF analysis. Respective protein spots 
were cut out of silver stained gels in order to pool sufficient amount of proteins. 
Proteins are indicated with their Uniprot accession numbers. 
Proteins of interest were searched via MASCOT (Matrix Science) in the public 
databases SwissProt and MSDB. 
Example for the MASCOT search result of Spot no. C12 (Actin PIG), database 
SwissProt: 
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Table 5: List of identified landmark proteins of PBMEC/C1-2 (PMF) 
Protein 
name 
Spot ID 
Master 
no* 
Acc.  
number 
PMF Score 
SwissProt** 
Sequ. 
Cov. 
[%] 
Matching  
peptides 
t-test 
value 
Av. 
Ratio 
Catalase 
Pig 
Spot C1 
 
O62839 64 11 5 0.075 - 0.36 
Pyruvate  
kinase 
isoenzyme 
Spot 
C11 
Q9UCV6 71 8 5 0.29 1.03 
Actin Pig 
Spot 
C12 
Q6QAQ1 93 25 8 -0.82 -1.23 
Master no*: defined landmark protein via Ethan Dige analyses, PMF Score**: protein score 
greater than 64 are significant (ρ<0.005)  
 
Figure 18: Identified landmark proteins of PBMEC/C1-2  
 
Positions of Spot C1, 
C11 and C12 at the 
PBMEC/C1-2, 2D Dige 
gel uninduced –marked 
with blue circles  
(pI 3 -11 NL, 12.5 %). 
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Table 6: List of identified proteins of HUVEC (PMF) 
Protein name 
Spot 
ID 
Ma. 
no 
Acc.  
nr. 
MSDB 
Acc. nr. 
Sw.Prot 
PMF 
Score  
* 
Sequ. 
Cov. 
[%] 
Matching  
peptides 
t-test 
value 
Av. 
Ratio 
Serum Albumin 
(bov.) 
Spot 
C6/ 
498 
AAI02743 P02769 102/84 19/6 11/10 0.023 -1.68 
Retinal 
dehydrogenase 
1 (h.s) 
Spot 
C7/ 
639 
DEHUE1 P00352 98/98 18/18 9/9 0.032 -1.76 
α– enolase 
(h.s) 
Spot 
C8/ 
626 
Q8WU71 P06733 
200/ 
199 
32/32 15/15 0.017 2.89 
Annexin A5 
(h.s) 
Spot  
C9/ 
979 
1HVE P08758 221/220 44/43 16/16 0.036 4.12 
Hsp 27 
(h.s) 
Spot 
C11/ 
1018 
HHHU27 P04792 112/112 32/32 7/7 0.009 5.01 
PMF Score*: protein score greater than 64 are significant (ρ<0.005)  
 
Table 7: Further identified landmark proteins of HUVEC (PMF) 
Protein 
name 
Spot ID 
Master 
no* 
Acc.  
number 
PMF 
Score 
** 
Sequ. 
Cov. 
[%] 
Matching  
peptides 
t-test 
value 
*** 
Av. 
Ratio 
GAPDH 
(human) 
Spot C2 P04406 73 17 5 0.083 - 1.36 
Spot C 3 P04406 73 14 5 0.083 -1.36 
Spot C 4 P04406 67 14 8 0.083 -1.36 
Master no*: defined landmark protein via Ethan Dige analyses, PMF Score**: protein score 
greater than 64 are significant (ρ<0.005) , *** t-test value: the three spots were merged to 
one cluster protein 
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Figure 19: The proteome pattern of HUVEC cells (uninduced) shows inside the marked 
region (yellow circle) the spot cluster of Glycerinaldehyde-3-phosphate dehydrogenase. 
 
PMF spectrum and Mascot Search Results 
Protein analysis was performed by the open source mass spectrometry tool mMass. 
PMF spectrometry was processed with the open source software. The identification 
was determined via database queries with the search engine Mascot (Matrix 
Science) in two different databases as Swissprot, MSDB. The protein identification 
was demonstrated by search results from spot C1, C12 (PBMEC/C1-2) and Spot C9 
(HUVEC). The other results from the listed spots are attached in chapter Appendices 
(B PMF spectra and Mascot search results).  
 
Position of Spot C2, C3 
and C4 (left to right) at 
the HUVEC 2D Dige 
gel uninduced –marked 
inside the yellow circle  
(pI 3 -11 NL, 12.5 %). 
C2,C3,C4  
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SPOT C1  
Spot C1 was cut out from 12.5 % 2D gel, silver stained. The proteome pattern origin 
from porcine brain microvessel endothelial cells (PBMEC/C1-2).  
Protein Identified: 
Catalase (CATA PIG) 
Search Parameters 
Database: SwissProt 
Taxonomy: Mammalia (mammals) 
Enzyme: Trypsin 
Type of search: Peptide Mass Fingerprint 
Fixed modification: Carbamidomethyl (C) 
Variable modification: Oxidation (MW), Oxidation (M) 
Mass values: Monoisotpic 
Missed cleavages: 1 
Mass tolerance: +/- 200 ppm 
 
 
Figure 20: PMF spectrum of spot no. C1 (PBMEC/C1-2) 
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SPOT C12  
Spot C1 was cut out from 12.5 % 2D gel, silver stained. The proteome pattern origin 
from porcine brain microvessel endothelial cells (PBMEC/C1-2).  
Protein Identified: 
Actin PIG 
 
Figure 22: PMF spectrum of spot no. C12 (PBMEC/C1-2) 
 
SPOT C9  
Spot C1 was cut out from 12.5 % 2D gel, silver stained. The proteome pattern origin 
from human umbilical vein cells (HUVEC).  
Protein Identified: 
Annexin V (homo sapiens) 
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Figure 24: PMF spectrum of spot no. C9 (HUVEC) 
 
The following PMF data were attached in chapter Appendices [B: PMF analysis data] 
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5 Discussion 
Proteome analysis is an important method for systemic biological research. The 
proteome pattern and their characterization give information about a variety of 
proteins which carry out different functions in the organism. As example, some 
proteins handle structure roles, serve as essential metabolic coordinators or 
participate in signal transduction pathways. Additionally, a huge amount of diverse 
proteins exists and each has its unique structure compound that contributes to the 
specific function. The key issue of this work is to study the proteome pattern of 
proteins from two different blood-brain barrier (BBB) endothelial cells, porcine brain 
microvessel endothelial cells (PBMEC/C1-2) and human umbilical vein cells 
(HUVEC), respectively.  
The permeability of the BBB has a major role in many diseases which is a hallmark 
for medical treatment. The properties of brain endothelial cells are strongly 
dependent on their surrounding cells which induce multiple factors, such as growth 
factors. According to literature reports (Rubin and Staddon 1999, Grant et al. 1998) it 
was found that astrocytes induce stimulating factors to the basal surface of brain 
capillary endothelial cells thereby contributing to the proper formation of the complete 
BBB phenotype. These chemical signals have effects on the induction and 
maintenance of the BBB. Additionally, those molecules influence the proper building 
of tight junctions which in turn are potential regulators of the brain permeability. 
The overall purpose was to establish three Transwell models of PBMEC and HUVEC 
with different cell cultivation conditions. The main intension was the observation of 
changes in the proteome pattern inside the cultivation systems (uninduced, induced 
system and co-culture). The “uninduced system” implicates the cultivation in 
respective growth media and acts as control. In the “induced system” cells were 
cultured in astrocyte enriched media (ACM) to build up BBB specific properties. 
Finally the “co-culture system” has typical BBB features due to the experimental 
setup by co-cultivation with astroglial cells, isolated from rat brain.  
Many BBB in vitro models exist and are more or less suitable to answer specific 
questions regarding brain pathology. Porcine brain endothelial cells (PBEC) are 
experimentally well established as in vitro models in human drug discovery research 
and are routinely used in clinical research (Neuhaus et al. 1991). General, it is 
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observed that astrocyte enriched media (ACM) also induce tight junction formation in 
BBB cells in comparison to co-cultivation with astrocytes. Both methods (ACM and 
co-culture) show efficient results in tight junction formation of BBB endothelial cells 
(Arthur et al. 1987). Moreover, astrocytes are able to induce tight junction properties 
in endothelial cells, also if they are not of nervous system origin (Janzer and Raff 
1987). These findings are important for establishing BBB models with human 
endothelial cells which do not origin from brain like HUVECs.  
Another aspect of this work is the comparison of the two different endothelial cell 
lines either of human or of porcine origin in terms of their suitability for proteomic 
investigations. In other words:  
1 Will it be possible to identify changes in the proteome pattern due to different 
cultivation conditions? 
2 Are porcine BBB endothelial cells (PBEC) comparable with human endothelial 
cells (HUVEC) for the investigation of specific brain issues using proteome 
analysis? 
First the observation during this work with the Transwell filter models between the 
three different cultivation condition and the experimental cell lines (PBMEC/C1-2, 
HUVEC) will be discussed. For in vitro experiments cells were seeded (80.000 
cells/cm2) directly on Transwell filter membranes which were embedded in suitable 
medium belonging to the cultivation model. The average cultivation period of 
PBMEC/C1-2 was about 4 days whereas HUVEC took approximately 5 days until 
reaching confluence, until the next step of cell lysis could follow. Interestingly, the gap 
between the cultivation duration lay at the induced system where the period differs up 
to three days. The density of the cell monolayer at Transwell filter systems was 
observed via visual checks under the microscope and transendothelial electrical 
resistance (TEER) measurements. Indeed, the interpretation of the TEER 
measurements was difficult because the values fluctuated among the probes. For co-
culture system of porcine cells (PBMEC/C1-2) no validTEER measurements could be 
conducted at the day before cell lysis. Probably the medium temperature between 
cultivation and calibration medium differed too much or another reason could be a 
loose connection of the meter. Independent measurements of two different operators 
excluded a handling error. Perhaps, a possibility to avoid fluctuation of TEER values 
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could be the use ofan automated transepithelial/-endothelilal measurement 
instrument such as cellZscope (nanoAnalytics, Münster, Germany). In summary no 
significant changes between the cultivation conditions were observed via TEER 
measurements. In contrast the comparison of the cell lines (PBMEC/C1-2, HUVEC) 
indicates changes in the cultivation period up to a maximum of six days. 
Second the analysis of the 2D-DIGE experiments from the cell line PBMEC/C1-2 and 
HUVEC showed a remarkable number of significantly changed proteins, within the 
three different cultivation systems. Further analysis of the gel series revealed a 
higher amount of significantly changed proteins within the proteome of the cell line 
PBMEC in comparison to proteome changes in HUVEC. The results showed different 
regulations of the proteome dependent on culture conditions and cell type indicating 
increased sensitivity of BBB cell line PBMEC/C1-2 to astrocytic signals compared to 
HUVECs. Significant changes in protein expressions of PBMEC were found for 
approximately 20 proteins in co-culture system versus uninduced system and about 
30 proteins of induced system versus uninduced. In contrast the amount of 
significantly changed HUVEC proteins was smaller than of PBMEC. Almost 15 
proteins could be detected for co-culture system and approximately 10 for induced 
system. This indicates a lower susceptibility of HUVECs for inducing factors derived 
from astrocytes. Some of the most remarkably changed proteins and defined 
landmark proteins out of Ettan DIGE software (verion 7.0) were identified by MALDI-
TOF MS experiments. The following table (Table 1: Biological functions of identified 
proteins) shows the function of the mass spectrometrically identified proteins from 
human and porcine cells.  
Table 1: Biological function of identified proteins via MS analyses 
Porcine brain microvessel endothelial cells (PBMEC/C1-2) 
Biological function Name of protein) Spot no. 
Stress response Catalase Spot C1 
Glucose metabolic process Pyruvate kinase isoenzyme Spot C11 
Compound of cytoskeleton Actin Spot C12 
Human umbilical vein endothelial cells (HUVEC) 
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Biological function Name of protein) Spot no. 
Regulation of blood pressure Serum Albumin Spot C6 
Retinol metabolism Retinal dehydrogenase 1 Spot C7 
Glycolytic function α-Enolase Spot C8 
Inhibition of blood coagulation Annexin A5 Spot C9 
Stress response Hsp 27 Spot C11 
Glucose metabolic process GAPDH Spot C2, C3, C4 
Table1: List of significant changing proteins and defined landmark proteins which are 
detected by MALDI TOF 
The listed proteins have several functions in metabolic processes or are involved in 
response to stress and regulation of blood homeostasis. A number of those proteins 
have important regulatory effects and act as biomarkers for diagnosing pathological 
circumstances. The following examples demonstrate the role of three identified 
proteins in the body under pathological disorders. 
According to literature (Habib et al. 2010) Catalase is involved in interactions for cell 
protection by catalyzing hydrogen peroxide (H2O2). This publication indicates the 
correlation of accumulation from the neurotoxic β-amyloid and oxidative stress inside 
the brain. These effects are often described in combination with Alzheimer disease 
(AD). In this case the activity of catalase is blocked by the interaction with harmful Aβ 
peptides which leads to the increase of high intracellular H2O2 levels. This study 
provides the importance of catalase for cell protection against induced oxidative 
stress by the interaction with Aβ. 
Alpha-enolase belongs to the family of cytoplasmic and glycolytic enzymes. The 
main function of this enzyme is not clear yet but it acts in a variety of infectious and 
autoimmune diseases. It has a major role in glycolytic processes of eukaryotes and 
prokaryotes (Terrier et. al 2006). 
Heat shock protein (Hsp) 27 is a stress responded protein that has repair and 
protective functions in the organism. Hsp27 is a common marker for tissue damage 
caused by oxidative stress. Corresponding to the publication (Bechtold and Brown 
2003) about the induction of Hsp27 in glial cells of mammalian rat brains during 
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hyperthermia it is documented that hyperthermia induces a rapid influx of heat shock 
proteins as Hsp27. In this study it is observed that the rapid induction of Hsp 27 to 
glial cells promotes the repair of stress induced cellular damage in during 
hyperthermia. 
Third the following questions which came up before starting the experimental part of 
this thesis, will be discussed. 
1.   Will it be possible to identify changes in the proteome pattern due to 
different cultivation conditions? 
The changes of the proteome pattern inside the three different cultivation conditions 
could be documented via DIGE analyses. There are significant changes in the 
proteome pattern of PBMEC/C1-2 and HUVEC. In comparison of the two astrocytic 
cultivation systems (co-culture, induced) with the uninduced system remarkable 
changes in the protein expression structure could be demonstrated. The number of 
significantly changed proteins differs between co-culture system and induced system 
up to a maximum of ten proteins. For PBMEC/C1-2 the induced system shows a 
higher amount of proteins with changing expression pattern compared to the co-
culture system. Interestingly, in contrast HUVEC reached the maximum of 
significantly changed proteins in the co-culture system. Summarizing, changes in the 
proteome pattern due to different cultivation conditions could be identified. 
2.   Are porcine BBB endothelial cells (PBEC) comparable with human 
endothelial cells (HUVEC) for the investigation of specific brain issues 
using proteome analysis? 
Based on the number of changes in the proteome, human umbilical vein cells seem 
to besusceptible for Blood-brain barrier inducing factors, but to a lower extent than 
PBMEC/C1-2.. During cell cultivation and mass spectrometry analyses no 
remarkable differences in handling the experiments could be determined. According 
to literature (Janzer and Raff 1987) it was documented that astrocytes are able to 
induce tight junction properties in endothelial cells, also if they are not of nervous 
system origin. This knowledge out of the publication was an important requirement in 
this work for choosing the proper human cell line to conduct in vitro BBB studies. 
Based on results from literature and the experiments of this study, porcine BBB 
endothelial cells (PBEC) are suitable to compare them with human endothelial cells 
(HUVEC) for the investigation of specific brain studies on the proteome. 
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Concluding, the results of this thesis demonstrate the a profound alteration of the 
proteome caused by astrocyte induction and can serve as a starting point for 
systemic observation of the mechanism and metabolic pathways that are involved. 
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6 Zusammenfassung 
Zielsetzung dieser Arbeit ist die Untersuchung von Dysfunktionsstudien an der 
Blut-Hirn Schranke (BBB) um potentielle „molecules of interest“ zu identifizieren. 
Durch die Herangehensweise des modernen systempharmakologischen Ansatzes 
liegt der Focus auf einer systematischen Analyse der „BBB als pharmakologisches 
drug target“ für in vitro Modellversuche. Modellstudien dienen als Vorstufe um 
Krankheitsmodelle zu verstehen und diese im weiteren Sinne auf die Situation des 
Patienten zu rekonstruieren. 
Die systempharmakologischen Studien dieser Masterarbeit liegen vor allem in der 
Untersuchung des Proteoms von Blut-Hirn Schranken Endothelzellen und dessen 
potentieller Veränderungen unter Einfluss verschiedener Kultivierungsbedingungen. 
Die Experimente wurden jeweils mit humanen Nabelschnur Endothel- (HUVEC) und 
porcinen Hirnkapillar-Endothel- (PBMEC/C1-2) Zelllinien durchgeführt. Die getesteten 
Kultivierungsbedingungen wurden in folgende Ansätze unterteilt: Co-Kultur; 
Induziert und Nicht induziert. Die Systeme Co-Kultur und Induziert beinhalten 
Faktoren, die Blut-Hirn Schranken Eigenschaften in Endothelzellen induzieren, 
wodurch sich eine Veränderung der sog. „tight junctions“ innerhalb der Zellen ergibt. 
Bei dem System Co-Kultur wird die experimentelle Endothelzelllinie gemeinsam mit 
Astrozyten, welche aus Rattenhirn isoliert wurden, kultiviert. Das System Induziert 
wird ausschließlich mit der experimentellen Endothelzelllinie durchgeführt, jedoch in 
einem Astrozyten-konditionierten Kultivierungsmedium (ACM).  
Mittels kontinuierlichen elektrischen Widerstandsmessungen (TEER) wurde die 
Zelldichte in den Kultivierungsmodellen bestimmt, um die Ausbildung eines dichten 
Monolayers zu verifizieren und anschließend die Zellen zu lysieren. Die 
Proteomanalyse der Zellextrakte erfolgte durch 2-D Gel Elektrophorese und MALDI 
TOF MS Technik. Anschließend erfolgte eine gezielte Selektion der Proteine von 
Interesse (POI), welche signifikante Expressionsänderungen aufwiesen.  
Einige dieser Proteinspots wurden massenspektrometrisch identifiziert, darunter z.B. 
Heat shock protein 27 (HSP27), Annexin A5, Aldehyddehydrogenase und Catalase. 
Diese biologisch relevanten Proteine sind „target Moleküle“ bei 
Neurodegeneration, oxidativen Stress, spielen eine Rolle in Entzündungsprozessen 
und sind Regulationsfaktoren der endothelialen Homöostase. Die Ergebnisse dieser 
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Arbeit  sind grundlegende Elemente einer pilot Studie und stellen weitere 
Ausgangspunkte für die fortlaufende Untersuchung von neurodegenerativen 
Vorgängen sowie weitere Aufklärung von Mechanismen zur Ausbildung von Blut-
Hirn-Schranken-Eigenschaften in Endothelzellmodellen dar. 
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7 Summary 
The aim of this work implicates modern system pharmacological studies which is 
the elucidation of complex physiological and pathological cellular processes and the 
analysis and identification of molecules of interests. The overall purpose of this 
study is to observe dysfunction processes of the blood-brain barrier (BBB) which 
obverse leads to pathological circumstances caused by neurodegeneration.  
This pilot study focuses on the proteomic analysis of BBB in vitro models, the 
influence of different cultivation conditions on barrier tightness and the proteomic 
pattern. 
Experiments were conducted with human umbilical vein endothelial cells (HUVEC) 
and porcine brain microvascular endothelial cells (PBMEC/C1-2). The in vitro 
investigations were conducted under three different cultivation conditions to observe 
changes on the proteome pattern. Both cell lines were cultivated as follows (a) “co-
culture system”, (b) “induced system”, (c)“ uninduced system”. The “co-culture 
system” comprises of the experimental cell lines (PBMEC/C1-2 or HUVEC) and 
astrocytic glial cells origin from rat brain. The “induced system” consists of enriced 
medium containing astrocytic factors (ACM) to induce BBB characteristics by 
changes in tight junctions (TJ). It is known that astrocytic derived soluble factors may 
induce the expression of BBB properties in endothelial cells in vitro (Janzer and Raff 
1987) 
Using transendothelial electrical resistance (TEER) measurements to verify the 
tightness of the cellular monolayer in Transwell filter systems. Subsequently, cells 
were lysed for proteomic analysis with 2D DIGE and MALDI TOF MS. Statistical 
analyses revealed differentially expressed protein spots. 
The identification of “molecules of interests” which indicate significantly changes of 
the proteome pattern inside the different cultivation conditions was performed via 
mass spectrometry. Examples for identified proteins as heat shock protein 27 
(HSP27), annexin A5, aldehyde dehydrogenase and catalase are target molecules 
for neurodegeneration oxidative stress, play a role in inflammatory processes and are 
regulation factors of endothelial homeostasis.  
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The results of this pilot study are profound starting points for further dysfunctional 
research to elucidate the biological mechanisms of the induction BBB characteristics 
in cell culture models. 
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A CV /Lebenslauf 
 
Lebenslauf 
 
Persönliche Daten 
 
Name Christiane Gebhard 
Anschrift Voltagasse 43/12/1 
 1210 Wien 
 
 Tel: 0650/8096592 
 Email: gebhard_christiane@gmx.at 
 
Geboren am 2. September 1983 
Familienstand ledig 
 
Schulbildung 
 
1990 – 1994 Volksschule in Wien 21, Priessnitzgasse 
 
1994 – 1998 Unterstufe am Gymnasium BRG 1 Schottenbastei 
 
1998 – 2003 Handelsakademie des Fonds der Wr. Kaufmannschaft in  
 Wien 21., Franklinstrasse 
 Abschluss mit Matura 
 
Studium 
 
Universitätsstudium 
 
2003 - 2008 Bachelorstudium Lebensmittel und Biotechnologie an der 
 Universität für Bodenkultur Wien 
 
2007-2008 Mitbelegung an der Uni Wien, Absolvierung der Auflagen für  
                              den Einstieg in das Masterstudium Molekularbiologie 
 
 
2008 – 2011 Masterstudium Molekularbiologie an der Universität Wien 
 Spezialisierung: Neurowissenschaften  am Zentrum für 
 Hirnforschung der Med. Uni  Wien 
 
 
Masterarbeit  
„Differential proteome analysis of blood brain barrier endothelia 
cells in vitro models“ 
 Betreuung: Univ.Prof.DI.Dr.Christian R. Noe  
 
 
Abschluss Master Science (MSc) 
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Fachhochschulstudium  
                               
2006- 2010 FH-Diplomstudium Bioengineering an der FH-Campus Wien 
 Spezialisierung: Qualitätsmanagement 
 
 
Diplomarbeit  
 "Untersuchungen zur Bestimmung der Wiederfindung von Keimen  
 auf Textilien im Kontext der nosokomialen Keimübertragung" 
 Betreuung:  Univ.Prof.DI.Dr. Rudolf F. Bliem 
 
Abschluss DI (FH) für technisch-wissenschaftliche Berufe 
 
 
 
Berufliche  Qualifikation 
 
2009 Auditor für  ISO 9001 
 Zertifizierungsstelle AuM der Technischen Universität Wien 
 
2010 Zertifikat Quality Manager 
  
 
Öffentliche Präsenz 
 
 
2009 Präsentation des wissenschaftlichen Posters zum Thema der 
 FH- Diplomarbeit ; an der Poster Session der FH-Campus Wien;  
 Universität für Bodenkultur (BOKU 
 
2010 Komiteemitglied sowie Vortrag zu ISO 9001  
 „Patientensicherheit und Mitarbeiterzufriedenheit bei der  
 Zertifizierung öffentlicher Gesundheitseinrichtungen“;   
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2010 Präsentation des wissenschaftlichen Posters zum Thema der 
 Uni – Masterarbeit; bei der  4th Central and Eastern European   
 Proteomics Conference (CEEPC meets IMA);  
 Technische Universität Wien (TU) 
 
 
Praktika und Berufserfahrung 
 
2011 Forschungsaufenthalt an der Universität Heidelberg 
 Abteilung für Pharmazie und Molekulare Biotechnologie 
 
2010 Universitätsassistentin (pre doc)  
am Institut für Medizinisch/Pharmazeutische Chemie 
Universität Wien 
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2009 Trainee bei der Firma TÜV AUSTRIA CERT GmbH 
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 in der EDV-Abteilung 
  
 
2004 Praktikum an der Universität für Veterinärmedizin 
 Institut für Pharmakologie und Toxikologie 
 Dauer: 2 Monate 
 
 
Sonstige Qualifikationen 
 
Sprachen Deutsch, Englisch, Spanisch     
 
EDV Microsoft Office, SPSS,  
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B PMF analysis data  
 
HUVEC 
Search Parameters 
Database: SwissProt /MSDB 
Enzyme: Trypsin 
Type of search: Peptide Mass Fingerprint 
Fixed modification: Carbamidomethyl (C) 
Variable modification: Oxidation (MW), Oxidation (M) 
Mass values: Monoisotpic 
Missed cleavages: 1 
 
Spot ID/ Master no.: Spot C6 / 498 
Mass tolerance: +/- 200 ppm 
 
Figure: PMF spectrum of spot no. C6 (HUVEC) 
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Spot ID/ Master no.: Spot C7 / 639 
Mass tolerance: +/- 100 ppm 
 
Figure: PMF spectrum of spot no. C7 (HUVEC) 
 
Spot ID/ Master no.: Spot C8 / 626 
Mass tolerance: +/- 200 ppm 
 
Figure: PMF spectrum of spot no. C8 (HUVEC) 
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Spot ID/ Master no.: Spot C11 / 1018 
Mass tolerance: +/- 200 ppm 
 
Figure: PMF spectrum of spot no. C11 (HUVEC) 
 
PBMEC/C1-2 
 
Spot ID/ Master no.: Spot C11  
Mass tolerance: +/- 200 ppm 
 
Figure: PMF spectrum of spot no. C11 (PBMEC/C1-2) 
